Cellosaurus logo
expasy logo

Cellosaurus MCF-7 (CVCL_0031)

[Text version]
Cell line name MCF-7
Synonyms MCF 7; MCF.7; MCF7; Michigan Cancer Foundation-7; ssMCF-7; ssMCF7; MCF7/WT; MCF7-CTRL; IBMF-7
Accession CVCL_0031
Resource Identification Initiative To cite this cell line use: MCF-7 (RRID:CVCL_0031)
Comments Group: Space-flown cell line (cellonaut).
Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
Part of: COSMIC cell lines project.
Part of: ENCODE project common cell types; tier 2.
Part of: JFCR39 cancer cell line panel.
Part of: JFCR45 cancer cell line panel.
Part of: GrayJW breast cancer cell line panel.
Part of: ICBP43 breast cancer cell line panel.
Part of: KuDOS 95 cell line panel.
Part of: MD Anderson Cell Lines Project.
Part of: NCI-60 cancer cell line panel.
Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-12584.
Registration: Chiron Master Culture Collection; CMCC 10377 (CMCC #10377).
Population: Caucasian.
Doubling time: 1.8 days (PubMed=9671407); 80 hours (PubMed=25984343); 24 hours (PubMed=9488600); 31.2 hours (PubMed=22628656); 25.3 hours (PubMed=24389870); 24.4 hours (PubMed=34238275); ~50 hours (Note=With a range of 30-72 hours) (DSMZ=ACC-115); 25.4 hours (NCI-DTP=MCF7); ~38 hours (PBCF); 56.47 hours (GrayJW panel).
Microsatellite instability: Stable (MSS) (PubMed=12661003; PubMed=23671654; Sanger).
Omics: Array-based CGH.
Omics: CTCF ChIP-seq epigenome analysis.
Omics: H2BK120ub ChIP-seq epigenome analysis.
Omics: H3K23ac ChIP-seq epigenome analysis.
Omics: H3K27ac ChIP-seq epigenome analysis.
Omics: H3K27me3 ChIP-seq epigenome analysis.
Omics: H3K36me3 ChIP-seq epigenome analysis.
Omics: H3K4me1 ChIP-seq epigenome analysis.
Omics: H3K4me3 ChIP-seq epigenome analysis.
Omics: H3K79me2 ChIP-seq epigenome analysis.
Omics: H3K9ac ChIP-seq epigenome analysis.
Omics: H3K9me3 ChIP-seq epigenome analysis.
Omics: H4K8ac ChIP-seq epigenome analysis.
Omics: CNV analysis.
Omics: CRISPR phenotypic screen.
Omics: Deep antibody staining analysis.
Omics: Deep exome analysis.
Omics: Deep phosphoproteome analysis.
Omics: Deep proteome analysis.
Omics: Deep quantitative proteome analysis.
Omics: DNA methylation analysis.
Omics: Fluorescence phenotype profiling.
Omics: Glycoproteome analysis by proteomics.
Omics: lncRNA expression profiling.
Omics: Metabolome analysis.
Omics: miRNA expression profiling.
Omics: Myristoylated proteins analysis by proteomics.
Omics: N-glycan profiling.
Omics: Protein expression by reverse-phase protein arrays.
Omics: shRNA library screening.
Omics: SNP array analysis.
Omics: Transcriptome analysis by microarray.
Omics: Transcriptome analysis by RNAseq.
Omics: Transcriptome analysis by serial analysis of gene expression (SAGE).
Omics: Transcriptome analysis by single cell RNAseq.
Omics: Virome analysis using proteomics.
Anecdotal: This is the first hormone-responsive breast cancer cell line to have been established.
Anecdotal: Have been flown in space on Foton-12 to study cytoskeleton architecture in microgravity (PubMed=11292682; PubMed=15002416).
Anecdotal: Used in a study utilising the fruit fly's olfactory system to detect cancer cells (PubMed=24389870).
Donor information: Helen Marion Mallon (sister Catherine Frances), the patient from which this cell line is derived was a nun at the Immaculate Heart of Mary convent in Monroe, Michigan (CelloPub=CLPUB00336).
Misspelling: MFC-7; Note=Occasionally.
Misspelling: MFC7; Note=Occasionally.
Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
Sequence variations
  • Gene deletion; HGNC; 1787; CDKN2A; Zygosity=Homozygous (PubMed=19593635).
  • Mutation; HGNC; 4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (PubMed=15361840; Cosmic-CLP; DepMap).
  • Mutation; HGNC; 8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (PubMed=17088437; PubMed=19593635; PubMed=28889351).
  • Mutation; HGNC; 11998; TP53; None_reported; -; Zygosity=- (PubMed=15900046).
HLA typing Source: PubMed=15748285
Class I
HLA-AA*02:01:01
HLA-BB*18,44
HLA-CC*05
Class II
HLA-DPDPB1*02:01:02,04:01
HLA-DQDQB1*02:01,06:02
HLA-DRDRB1*03,15

Source: PubMed=25960936
Class I
HLA-AA*02:01,02:01
HLA-BB*18:01,44:02
HLA-CC*05:01,05:01
Class II
HLA-DQDQA1*01:02,01:02
DQB1*06:02,06:02
HLA-DRDRB1*15:01,15:01

Source: PubMed=26589293
Class I
HLA-AA*02:01,02:01
HLA-BB*18:01,35:01
HLA-CC*05:01,05:01
Genome ancestry Source: PubMed=30894373

Origin% genome
African0.74
Native American0
East Asian, North4.2
East Asian, South0
South Asian0
European, North56.91
European, South38.15
Disease Invasive breast carcinoma of no special type (NCIt: C4194)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Hierarchy Children:
CVCL_B8S1 (Abcam MCF-7 ABCC1 KO)CVCL_B8S2 (Abcam MCF-7 ABL2 KO)CVCL_B8S3 (Abcam MCF-7 ACKR3 KO)
CVCL_B8S4 (Abcam MCF-7 ACTA2 KO)CVCL_B8S5 (Abcam MCF-7 ACVR1B KO)CVCL_D2DP (Abcam MCF-7 ADA KO)
CVCL_B8S6 (Abcam MCF-7 ADAM10 KO)CVCL_D2DQ (Abcam MCF-7 ADAR KO)CVCL_D2DR (Abcam MCF-7 ADK KO)
CVCL_D2DS (Abcam MCF-7 ADORA2A KO)CVCL_D2DT (Abcam MCF-7 ADRA2B KO)CVCL_B8S7 (Abcam MCF-7 ADRB2 KO)
CVCL_D2DU (Abcam MCF-7 AFP KO)CVCL_B8S8 (Abcam MCF-7 AGO2 KO)CVCL_D2DV (Abcam MCF-7 AGO4 KO)
CVCL_B8S9 (Abcam MCF-7 AKT1 KO)CVCL_B8SA (Abcam MCF-7 AKT2 KO)CVCL_B8SB (Abcam MCF-7 AKT3 KO)
CVCL_B8SC (Abcam MCF-7 ALKBH5 KO)CVCL_B8SD (Abcam MCF-7 ANGPT1 KO)CVCL_B8SE (Abcam MCF-7 ANGPT2 KO)
CVCL_B8SF (Abcam MCF-7 ANXA1 KO)CVCL_B8SG (Abcam MCF-7 AQP4 KO)CVCL_B8SH (Abcam MCF-7 AR KO)
CVCL_B8SI (Abcam MCF-7 ARAF KO)CVCL_D2DW (Abcam MCF-7 AREG KO)CVCL_B8SJ (Abcam MCF-7 ARID1A KO)
CVCL_B8SK (Abcam MCF-7 ARID1B KO)CVCL_B8SL (Abcam MCF-7 ARNT KO)CVCL_D1UZ (Abcam MCF-7 ARNTL KO)
CVCL_B0ZT (Abcam MCF-7 ATAD2 KO)CVCL_B8SM (Abcam MCF-7 ATF2 KO)CVCL_D2DX (Abcam MCF-7 ATF6 KO)
CVCL_B0ZU (Abcam MCF-7 ATM KO)CVCL_B8SN (Abcam MCF-7 ATRX KO)CVCL_B8SP (Abcam MCF-7 AXIN1 KO)
CVCL_B8SQ (Abcam MCF-7 B2M KO)CVCL_D2DY (Abcam MCF-7 BAD KO)CVCL_B8SR (Abcam MCF-7 BARD1 KO)
CVCL_B8SS (Abcam MCF-7 BAX KO)CVCL_D2DZ (Abcam MCF-7 BCAR1 KO)CVCL_B8ST (Abcam MCF-7 BCL10 KO)
CVCL_B8SU (Abcam MCF-7 BCL11A KO)CVCL_B8SV (Abcam MCF-7 BCL11B KO)CVCL_B8SW (Abcam MCF-7 BCL2 KO)
CVCL_B8SX (Abcam MCF-7 BCL3 KO)CVCL_B8SY (Abcam MCF-7 BCL6 KO)CVCL_D2E0 (Abcam MCF-7 BHLHE40 KO)
CVCL_B8SZ (Abcam MCF-7 BLM KO)CVCL_B0ZV (Abcam MCF-7 BMI1 KO)CVCL_B8T0 (Abcam MCF-7 BMPR1A KO)
CVCL_B8T1 (Abcam MCF-7 BRAF KO)CVCL_B8T2 (Abcam MCF-7 BRCA1 KO)CVCL_B8T3 (Abcam MCF-7 BRCA2 KO)
CVCL_B8T4 (Abcam MCF-7 BRD3 KO)CVCL_B0ZW (Abcam MCF-7 BRD4 KO)CVCL_B8T5 (Abcam MCF-7 BRD7 KO)
CVCL_B8T6 (Abcam MCF-7 BRIP1 KO)CVCL_D2E1 (Abcam MCF-7 C3AR1 KO)CVCL_D2E2 (Abcam MCF-7 C5AR1 KO)
CVCL_B8T7 (Abcam MCF-7 CA9 KO)CVCL_B8T8 (Abcam MCF-7 CALR KO)CVCL_B8T9 (Abcam MCF-7 CARD11 KO)
CVCL_D2E3 (Abcam MCF-7 CARD9 KO)CVCL_B8TA (Abcam MCF-7 CARM1 KO)CVCL_B8TB (Abcam MCF-7 CASP8 KO)
CVCL_B8TC (Abcam MCF-7 CBL KO)CVCL_B8TD (Abcam MCF-7 CBLB KO)CVCL_B8TE (Abcam MCF-7 CCND2 KO)
CVCL_B8TF (Abcam MCF-7 CCNE1 KO)CVCL_D2E4 (Abcam MCF-7 CCR3 KO)CVCL_B8TG (Abcam MCF-7 CCR4 KO)
CVCL_D2E5 (Abcam MCF-7 CCR5 KO)CVCL_B8TH (Abcam MCF-7 CCR6 KO)CVCL_B8TI (Abcam MCF-7 CCR7 KO)
CVCL_D2E6 (Abcam MCF-7 CCR9 KO)CVCL_B8TJ (Abcam MCF-7 CD14 KO)CVCL_B8TK (Abcam MCF-7 CD19 KO)
CVCL_B8TL (Abcam MCF-7 CD209 KO)CVCL_D2E7 (Abcam MCF-7 CD226 KO)CVCL_B8TM (Abcam MCF-7 CD28 KO)
CVCL_D2E8 (Abcam MCF-7 CD34 KO)CVCL_B8TN (Abcam MCF-7 CD3E KO)CVCL_B8TP (Abcam MCF-7 CD4 KO)
CVCL_D2E9 (Abcam MCF-7 CD5 KO)CVCL_D2EA (Abcam MCF-7 CD69 KO)CVCL_D2EB (Abcam MCF-7 CD7 KO)
CVCL_B8TQ (Abcam MCF-7 CD74 KO)CVCL_B8TR (Abcam MCF-7 CD79A KO)CVCL_B8TS (Abcam MCF-7 CD80 KO)
CVCL_B8TT (Abcam MCF-7 CD86 KO)CVCL_B8TU (Abcam MCF-7 CDH11 KO)CVCL_B8TV (Abcam MCF-7 CDK2 KO)
CVCL_B8TW (Abcam MCF-7 CDK5 KO)CVCL_B8TX (Abcam MCF-7 CDK6 KO)CVCL_B8TY (Abcam MCF-7 CDK8 KO)
CVCL_B8TZ (Abcam MCF-7 CDKN1A KO)CVCL_B8U0 (Abcam MCF-7 CDKN1B KO)CVCL_D2EC (Abcam MCF-7 CDKN1C KO)
CVCL_B8U1 (Abcam MCF-7 CDX2 KO)CVCL_B8U2 (Abcam MCF-7 CEACAM5 KO)CVCL_B8U3 (Abcam MCF-7 CEBPA KO)
CVCL_B8U4 (Abcam MCF-7 CHD5 KO)CVCL_D2ED (Abcam MCF-7 CHD7 KO)CVCL_D2EE (Abcam MCF-7 CHD8 KO)
CVCL_B8U5 (Abcam MCF-7 CHD9 KO)CVCL_B8U6 (Abcam MCF-7 CHUK KO)CVCL_D2EF (Abcam MCF-7 CIRBP KO)
CVCL_D2EG (Abcam MCF-7 CISH KO)CVCL_D2EH (Abcam MCF-7 CLDN18 KO)CVCL_B8U7 (Abcam MCF-7 CLOCK KO)
CVCL_D2EI (Abcam MCF-7 CNOT6 KO)CVCL_B8U8 (Abcam MCF-7 CNTNAP2 KO)CVCL_B8U9 (Abcam MCF-7 COL1A1 KO)
CVCL_D2EJ (Abcam MCF-7 CR2 KO)CVCL_D2EK (Abcam MCF-7 CRBN KO)CVCL_B8UA (Abcam MCF-7 CREB1 KO)
CVCL_B8UB (Abcam MCF-7 CREBBP KO)CVCL_B8UC (Abcam MCF-7 CRLF2 KO)CVCL_D2EL (Abcam MCF-7 CSF1 KO)
CVCL_B8UD (Abcam MCF-7 CSF1R KO)CVCL_B8UE (Abcam MCF-7 CSF3R KO)CVCL_D2EM (Abcam MCF-7 CSPG4 KO)
CVCL_B8UF (Abcam MCF-7 CTLA4 KO)CVCL_B8UG (Abcam MCF-7 CTNNB1 KO)CVCL_D2EN (Abcam MCF-7 CX3CL1 KO)
CVCL_D2EP (Abcam MCF-7 CXCL11 KO)CVCL_D2EQ (Abcam MCF-7 CXCL13 KO)CVCL_B8UH (Abcam MCF-7 CXCR1 KO)
CVCL_D2ER (Abcam MCF-7 CXCR3 KO)CVCL_B8UI (Abcam MCF-7 CXCR4 KO)CVCL_D2ES (Abcam MCF-7 CXCR6 KO)
CVCL_B8UJ (Abcam MCF-7 CYBB KO)CVCL_B8UK (Abcam MCF-7 CYLD KO)CVCL_B8UL (Abcam MCF-7 DAXX KO)
CVCL_B8UM (Abcam MCF-7 DCC KO)CVCL_B8UN (Abcam MCF-7 DDB2 KO)CVCL_B8UP (Abcam MCF-7 DDR1 KO)
CVCL_B8UQ (Abcam MCF-7 DDR2 KO)CVCL_D2ET (Abcam MCF-7 DDX4 KO)CVCL_B8UR (Abcam MCF-7 DDX5 KO)
CVCL_B8US (Abcam MCF-7 DEPTOR KO)CVCL_B8UT (Abcam MCF-7 DGCR8 KO)CVCL_D2EU (Abcam MCF-7 DLL3 KO)
CVCL_B8UU (Abcam MCF-7 DMC1 KO)CVCL_B8UV (Abcam MCF-7 DNAJB1 KO)CVCL_B8UW (Abcam MCF-7 DNMT1 KO)
CVCL_B8UX (Abcam MCF-7 DNMT3B KO)CVCL_B8UY (Abcam MCF-7 DOT1L KO)CVCL_D2EV (Abcam MCF-7 DPP4 KO)
CVCL_B8UZ (Abcam MCF-7 DROSHA KO)CVCL_B8V0 (Abcam MCF-7 DUSP4 KO)CVCL_B8V1 (Abcam MCF-7 E2F1 KO)
CVCL_D2EW (Abcam MCF-7 E2F2 KO)CVCL_B8V2 (Abcam MCF-7 EBF1 KO)CVCL_B8V3 (Abcam MCF-7 EBI3 KO)
CVCL_B8V4 (Abcam MCF-7 EGF KO)CVCL_B8V5 (Abcam MCF-7 EGFR KO)CVCL_D2EX (Abcam MCF-7 EGLN3 KO)
CVCL_D2EY (Abcam MCF-7 EGR1 KO)CVCL_B8V6 (Abcam MCF-7 EHMT1 KO)CVCL_D2EZ (Abcam MCF-7 EIF2AK3 KO)
CVCL_D2F0 (Abcam MCF-7 ELK1 KO)CVCL_D2F1 (Abcam MCF-7 ENTPD1 KO)CVCL_D2F2 (Abcam MCF-7 EOMES KO)
CVCL_B8V7 (Abcam MCF-7 EP300 KO)CVCL_B8V8 (Abcam MCF-7 EPC1 KO)CVCL_B8V9 (Abcam MCF-7 EPHA3 KO)
CVCL_B8VA (Abcam MCF-7 EPHB2 KO)CVCL_B8VB (Abcam MCF-7 ERBB2 KO)CVCL_B8VC (Abcam MCF-7 ERBB3 KO)
CVCL_B8VD (Abcam MCF-7 ERBB4 KO)CVCL_B8VE (Abcam MCF-7 ERCC4 KO)CVCL_B8VF (Abcam MCF-7 ERCC5 KO)
CVCL_B8VG (Abcam MCF-7 ESR1 KO)CVCL_D2F3 (Abcam MCF-7 ESRRA KO)CVCL_B8VH (Abcam MCF-7 ETS1 KO)
CVCL_B8VI (Abcam MCF-7 ETV6 KO)CVCL_B8VJ (Abcam MCF-7 EZH1 KO)CVCL_B8VK (Abcam MCF-7 FANCA KO)
CVCL_B8VL (Abcam MCF-7 FANCD2 KO)CVCL_D2F4 (Abcam MCF-7 FAP KO)CVCL_B8VM (Abcam MCF-7 FAS KO)
CVCL_B8VN (Abcam MCF-7 FBXO38 KO)CVCL_B8VP (Abcam MCF-7 FCER2 KO)CVCL_B8VQ (Abcam MCF-7 FCGR2A KO)
CVCL_B8VR (Abcam MCF-7 FCGR2B KO)CVCL_B8VS (Abcam MCF-7 FCGR3A KO)CVCL_B8VT (Abcam MCF-7 FEN1 KO)
CVCL_B8VU (Abcam MCF-7 FGFR2 KO)CVCL_B8VV (Abcam MCF-7 FGFR4 KO)CVCL_B8VW (Abcam MCF-7 FLI1 KO)
CVCL_B8VX (Abcam MCF-7 FLT1 KO)CVCL_D2FB (Abcam MCF-7 FLT3LG KO)CVCL_B8VY (Abcam MCF-7 FLT4 KO)
CVCL_B8VZ (Abcam MCF-7 FN1 KO)CVCL_D2F5 (Abcam MCF-7 FOLR1 KO)CVCL_B8W0 (Abcam MCF-7 FOS KO)
CVCL_B8W1 (Abcam MCF-7 FOSL1 KO)CVCL_D2F6 (Abcam MCF-7 FOXA2 KO)CVCL_D2F7 (Abcam MCF-7 FOXC1 KO)
CVCL_D2F8 (Abcam MCF-7 FOXC2 KO)CVCL_D2F9 (Abcam MCF-7 FOXG1 KO)CVCL_B8W2 (Abcam MCF-7 FOXM1 KO)
CVCL_B8W3 (Abcam MCF-7 FOXO4 KO)CVCL_B8W4 (Abcam MCF-7 FOXP1 KO)CVCL_D2FA (Abcam MCF-7 FOXP3 KO)
CVCL_B8W5 (Abcam MCF-7 FTO KO)CVCL_B8W6 (Abcam MCF-7 GABRA1 KO)CVCL_B8W7 (Abcam MCF-7 GABRG2 KO)
CVCL_D2FC (Abcam MCF-7 GADD45B KO)CVCL_B8W8 (Abcam MCF-7 GATA1 KO)CVCL_B8W9 (Abcam MCF-7 GATA2 KO)
CVCL_D2FD (Abcam MCF-7 GATA4 KO)CVCL_D2FE (Abcam MCF-7 GATA6 KO)CVCL_B8WA (Abcam MCF-7 GLI1 KO)
CVCL_B8WB (Abcam MCF-7 GLI2 KO)CVCL_B8WC (Abcam MCF-7 GLS KO)CVCL_B8WD (Abcam MCF-7 GP1BA KO)
CVCL_D2FF (Abcam MCF-7 GPER1 KO)CVCL_B8WE (Abcam MCF-7 GPNMB KO)CVCL_B8WF (Abcam MCF-7 GSK3B KO)
CVCL_B8WG (Abcam MCF-7 GSR KO)CVCL_D2FG (Abcam MCF-7 GZMB KO)CVCL_B8WH (Abcam MCF-7 HAT1 KO)
CVCL_D2FH (Abcam MCF-7 HAVCR2 KO)CVCL_B8WI (Abcam MCF-7 HCN1 KO)CVCL_B8WJ (Abcam MCF-7 HDAC1 KO)
CVCL_B8WK (Abcam MCF-7 HDAC2 KO)CVCL_B8WL (Abcam MCF-7 HDAC4 KO)CVCL_B8WM (Abcam MCF-7 HDAC5 KO)
CVCL_B8WN (Abcam MCF-7 HDAC6 KO)CVCL_B8WP (Abcam MCF-7 HDAC7 KO)CVCL_B8WQ (Abcam MCF-7 HELQ KO)
CVCL_B0ZX (Abcam MCF-7 HES1 KO)CVCL_B8WR (Abcam MCF-7 HEY1 KO)CVCL_B8WS (Abcam MCF-7 HGF KO)
CVCL_D2FI (Abcam MCF-7 HIST2H2BE KO)CVCL_B8WT (Abcam MCF-7 HLA-A KO)CVCL_B8WU (Abcam MCF-7 HLA-DRA KO)
CVCL_D2FJ (Abcam MCF-7 HLA-G KO)CVCL_B8WV (Abcam MCF-7 HMGA2 KO)CVCL_B8WW (Abcam MCF-7 HNF1A KO)
CVCL_D2FK (Abcam MCF-7 HNF4A KO)CVCL_B8WX (Abcam MCF-7 HOXA9 KO)CVCL_D2FL (Abcam MCF-7 HPSE KO)
CVCL_B8WY (Abcam MCF-7 HRAS KO)CVCL_D2FM (Abcam MCF-7 ICAM1 KO)CVCL_B8WZ (Abcam MCF-7 ICOS KO)
CVCL_D2FN (Abcam MCF-7 ICOSLG KO)CVCL_B8X0 (Abcam MCF-7 IDH1 KO)CVCL_B8X1 (Abcam MCF-7 IDH2 KO)
CVCL_D2FP (Abcam MCF-7 IFITM1 KO)CVCL_D2FQ (Abcam MCF-7 IFNAR1 KO)CVCL_B8X2 (Abcam MCF-7 IFNB1 KO)
CVCL_B8X3 (Abcam MCF-7 IFNGR1 KO)CVCL_B8X4 (Abcam MCF-7 IFNGR2 KO)CVCL_B8X5 (Abcam MCF-7 IGF1 KO)
CVCL_B8X6 (Abcam MCF-7 IGF1R KO)CVCL_D2FR (Abcam MCF-7 IGF2BP1 KO)CVCL_B8X7 (Abcam MCF-7 IGF2BP2 KO)
CVCL_D2FS (Abcam MCF-7 IGF2BP3 KO)CVCL_D2FT (Abcam MCF-7 IKBKE KO)CVCL_B8X8 (Abcam MCF-7 IL12A KO)
CVCL_B8X9 (Abcam MCF-7 IL18 KO)CVCL_B8XA (Abcam MCF-7 IL1A KO)CVCL_B8XB (Abcam MCF-7 IL1B KO)
CVCL_D2FU (Abcam MCF-7 IL23R KO)CVCL_B8XC (Abcam MCF-7 IL27 KO)CVCL_B8XD (Abcam MCF-7 IL2RB KO)
CVCL_B8XE (Abcam MCF-7 IL3RA KO)CVCL_B8XF (Abcam MCF-7 IL6R KO)CVCL_B8XG (Abcam MCF-7 IL7R KO)
CVCL_D2FV (Abcam MCF-7 IL9 KO)CVCL_B8XH (Abcam MCF-7 INPP5D KO)CVCL_D2FW (Abcam MCF-7 IQGAP1 KO)
CVCL_D2FX (Abcam MCF-7 IRAK1 KO)CVCL_B8XI (Abcam MCF-7 IRAK4 KO)CVCL_B8XJ (Abcam MCF-7 IRF4 KO)
CVCL_B8XK (Abcam MCF-7 ITGA2 KO)CVCL_B8XL (Abcam MCF-7 ITGAE KO)CVCL_B8XM (Abcam MCF-7 ITGAL KO)
CVCL_B8XN (Abcam MCF-7 ITGAM KO)CVCL_B8XP (Abcam MCF-7 ITGAV KO)CVCL_B8XQ (Abcam MCF-7 ITGAX KO)
CVCL_B8XR (Abcam MCF-7 ITGB1 KO)CVCL_B8XS (Abcam MCF-7 ITK KO)CVCL_B8XT (Abcam MCF-7 ITPR1 KO)
CVCL_B8XU (Abcam MCF-7 JAK1 KO)CVCL_B8XV (Abcam MCF-7 JAK3 KO)CVCL_D2FY (Abcam MCF-7 JARID2 KO)
CVCL_B8XW (Abcam MCF-7 KAT2B KO)CVCL_B8XX (Abcam MCF-7 KDM1A KO)CVCL_B8XY (Abcam MCF-7 KDM3A KO)
CVCL_B8XZ (Abcam MCF-7 KDM5A KO)CVCL_B8Y0 (Abcam MCF-7 KDM5B KO)CVCL_B8Y1 (Abcam MCF-7 KDM6A KO)
CVCL_B8Y2 (Abcam MCF-7 KDR KO)CVCL_B8Y3 (Abcam MCF-7 KEAP1 KO)CVCL_B8Y4 (Abcam MCF-7 KIT KO)
CVCL_D2FZ (Abcam MCF-7 KITLG KO)CVCL_B8Y5 (Abcam MCF-7 KLF4 KO)CVCL_D2G0 (Abcam MCF-7 KLRB1 KO)
CVCL_D2G1 (Abcam MCF-7 KLRC1 KO)CVCL_B8Y6 (Abcam MCF-7 KMT2A KO)CVCL_B8Y7 (Abcam MCF-7 KMT2D KO)
CVCL_D2G2 (Abcam MCF-7 KRT1 KO)CVCL_D2G3 (Abcam MCF-7 LAMP1 KO)CVCL_B8Y8 (Abcam MCF-7 LATS1 KO)
CVCL_B8Y9 (Abcam MCF-7 LATS2 KO)CVCL_B8YA (Abcam MCF-7 LCK KO)CVCL_D2G4 (Abcam MCF-7 LGALS1 KO)
CVCL_D2G5 (Abcam MCF-7 LGALS3 KO)CVCL_D2G6 (Abcam MCF-7 LGR5 KO)CVCL_D2G7 (Abcam MCF-7 LILRB1 KO)
CVCL_D2G8 (Abcam MCF-7 LIN28A KO)CVCL_D2G9 (Abcam MCF-7 LIN28B KO)CVCL_B8YB (Abcam MCF-7 LMNA KO)
CVCL_B8YC (Abcam MCF-7 LRP5 KO)CVCL_B8YD (Abcam MCF-7 LYN KO)CVCL_B8YE (Abcam MCF-7 MAF KO)
CVCL_B8YF (Abcam MCF-7 MALT1 KO)CVCL_B8YG (Abcam MCF-7 MAP2K1 KO)CVCL_B8YH (Abcam MCF-7 MAP2K2 KO)
CVCL_B8YI (Abcam MCF-7 MAP2K4 KO)CVCL_B8YJ (Abcam MCF-7 MAP3K11 KO)CVCL_B8YK (Abcam MCF-7 MAP3K7 KO)
CVCL_B8YL (Abcam MCF-7 MAPK1 KO)CVCL_B8YM (Abcam MCF-7 MAPK14 KO)CVCL_B8YN (Abcam MCF-7 MAPK3 KO)
CVCL_B8YP (Abcam MCF-7 MDC1 KO)CVCL_B8YQ (Abcam MCF-7 MECOM KO)CVCL_D2GA (Abcam MCF-7 MECP2 KO)
CVCL_B8YR (Abcam MCF-7 MED12 KO)CVCL_B8YS (Abcam MCF-7 MEN1 KO)CVCL_D2GB (Abcam MCF-7 MEF2A KO)
CVCL_D2GC (Abcam MCF-7 MEF2C KO)CVCL_B8YT (Abcam MCF-7 MET KO)CVCL_B8YU (Abcam MCF-7 MGMT KO)
CVCL_D2GD (Abcam MCF-7 MICA KO)CVCL_D2GE (Abcam MCF-7 MICB KO)CVCL_B8YV (Abcam MCF-7 MITF KO)
CVCL_D2GF (Abcam MCF-7 MKI67 KO)CVCL_B8YW (Abcam MCF-7 MLH1 KO)CVCL_B8YX (Abcam MCF-7 MMP1 KO)
CVCL_B8YY (Abcam MCF-7 MMP12 KO)CVCL_B8YZ (Abcam MCF-7 MMP2 KO)CVCL_B8Z0 (Abcam MCF-7 MMP9 KO)
CVCL_B8Z1 (Abcam MCF-7 MRE11 KO)CVCL_B8Z2 (Abcam MCF-7 MSH2 KO)CVCL_D2GG (Abcam MCF-7 MSH3 KO)
CVCL_B8Z3 (Abcam MCF-7 MSH6 KO)CVCL_D2GH (Abcam MCF-7 MSLN KO)CVCL_B8Z4 (Abcam MCF-7 MSR1 KO)
CVCL_B8Z5 (Abcam MCF-7 MTA2 KO)CVCL_B8Z6 (Abcam MCF-7 MUC1 KO)CVCL_B8Z7 (Abcam MCF-7 MUC16 KO)
CVCL_B8Z8 (Abcam MCF-7 MYB KO)CVCL_B8Z9 (Abcam MCF-7 MYD88 KO)CVCL_B8ZA (Abcam MCF-7 MYOD1 KO)
CVCL_D2GI (Abcam MCF-7 NANOG KO)CVCL_B8ZB (Abcam MCF-7 NBN KO)CVCL_B8ZC (Abcam MCF-7 NCAM1 KO)
CVCL_D2GJ (Abcam MCF-7 NCAM2 KO)CVCL_D2GK (Abcam MCF-7 NCF4 KO)CVCL_B8ZD (Abcam MCF-7 NCOA1 KO)
CVCL_D2GL (Abcam MCF-7 NCR1 KO)CVCL_D2GM (Abcam MCF-7 NECTIN2 KO)CVCL_D2GN (Abcam MCF-7 NECTIN3 KO)
CVCL_B8ZE (Abcam MCF-7 NF1 KO)CVCL_B8ZF (Abcam MCF-7 NF2 KO)CVCL_D2GP (Abcam MCF-7 NFATC1 KO)
CVCL_B8ZG (Abcam MCF-7 NFATC2 KO)CVCL_B8ZH (Abcam MCF-7 NFE2L2 KO)CVCL_B8ZI (Abcam MCF-7 NOS2 KO)
CVCL_B8ZJ (Abcam MCF-7 NOTCH1 KO)CVCL_B8ZK (Abcam MCF-7 NOTCH2 KO)CVCL_D2GQ (Abcam MCF-7 NR1H3 KO)
CVCL_B8ZL (Abcam MCF-7 NR4A1 KO)CVCL_B8ZM (Abcam MCF-7 NR4A3 KO)CVCL_B8ZN (Abcam MCF-7 NRAS KO)
CVCL_B8ZP (Abcam MCF-7 NSD2 KO)CVCL_D2GR (Abcam MCF-7 NTRK2 KO)CVCL_B8ZQ (Abcam MCF-7 NTRK3 KO)
CVCL_B8ZR (Abcam MCF-7 OLIG2 KO)CVCL_B8ZS (Abcam MCF-7 OPRM1 KO)CVCL_B8ZT (Abcam MCF-7 PAK1 KO)
CVCL_B8ZU (Abcam MCF-7 PAK2 KO)CVCL_D2GS (Abcam MCF-7 PAK4 KO)CVCL_B8ZV (Abcam MCF-7 PALB2 KO)
CVCL_B8ZW (Abcam MCF-7 PARP1 KO)CVCL_B8ZX (Abcam MCF-7 PARP3 KO)CVCL_B8ZY (Abcam MCF-7 PAX5 KO)
CVCL_D2GT (Abcam MCF-7 PAX6 KO)CVCL_B8ZZ (Abcam MCF-7 PAX7 KO)CVCL_B9A0 (Abcam MCF-7 PAX8 KO)
CVCL_B9A1 (Abcam MCF-7 PBRM1 KO)CVCL_B9A2 (Abcam MCF-7 PDCD1 KO)CVCL_B0ZY (Abcam MCF-7 PDE3B KO)
CVCL_B9A3 (Abcam MCF-7 PDGFB KO)CVCL_B9A4 (Abcam MCF-7 PDGFRA KO)CVCL_B9A5 (Abcam MCF-7 PDGFRB KO)
CVCL_D2GU (Abcam MCF-7 PDPN KO)CVCL_D2GV (Abcam MCF-7 PEBP1 KO)CVCL_D2GW (Abcam MCF-7 PECAM1 KO)
CVCL_B9A6 (Abcam MCF-7 PER1 KO)CVCL_B9A7 (Abcam MCF-7 PGF KO)CVCL_B9A8 (Abcam MCF-7 PGR KO)
CVCL_B9A9 (Abcam MCF-7 PHF1 KO)CVCL_B9AA (Abcam MCF-7 PHLPP1 KO)CVCL_B9AB (Abcam MCF-7 PIK3R1 KO)
CVCL_B9AC (Abcam MCF-7 PIK3R2 KO)CVCL_D2GX (Abcam MCF-7 PIWIL4 KO)CVCL_D2GY (Abcam MCF-7 PMEL KO)
CVCL_B9AD (Abcam MCF-7 PML KO)CVCL_B9AE (Abcam MCF-7 PMS2 KO)CVCL_B9AF (Abcam MCF-7 POLQ KO)
CVCL_B9AG (Abcam MCF-7 POLR2A KO)CVCL_D2GZ (Abcam MCF-7 POU2F2 KO)CVCL_B9AH (Abcam MCF-7 POU5F1 KO)
CVCL_D2H0 (Abcam MCF-7 PPARA KO)CVCL_D2H1 (Abcam MCF-7 PPARD KO)CVCL_B9AI (Abcam MCF-7 PPARG KO)
CVCL_B9AJ (Abcam MCF-7 PRDM1 KO)CVCL_B9AK (Abcam MCF-7 PRDM16 KO)CVCL_B9AL (Abcam MCF-7 PRF1 KO)
CVCL_B9AM (Abcam MCF-7 PRKAA1 KO)CVCL_B9AN (Abcam MCF-7 PRKAA2 KO)CVCL_D2H2 (Abcam MCF-7 PRKAR1A KO)
CVCL_B9AP (Abcam MCF-7 PRKCA KO)CVCL_B9AQ (Abcam MCF-7 PRKCB KO)CVCL_B9AR (Abcam MCF-7 PROCR KO)
CVCL_B9AS (Abcam MCF-7 PROX1 KO)CVCL_B9AT (Abcam MCF-7 PTEN KO)CVCL_B9AU (Abcam MCF-7 PTGS1 KO)
CVCL_D2H3 (Abcam MCF-7 PTN KO)CVCL_D2H4 (Abcam MCF-7 PTPN1 KO)CVCL_B9AV (Abcam MCF-7 PTPN2 KO)
CVCL_B9AW (Abcam MCF-7 PTPN6 KO)CVCL_B9AX (Abcam MCF-7 RAD50 KO)CVCL_B9AY (Abcam MCF-7 RAD51D KO)
CVCL_D2H5 (Abcam MCF-7 RAET1E KO)CVCL_B9AZ (Abcam MCF-7 RAF1 KO)CVCL_B9B0 (Abcam MCF-7 RARB KO)
CVCL_B9B1 (Abcam MCF-7 RB1 KO)CVCL_B9B2 (Abcam MCF-7 REL KO)CVCL_B9B3 (Abcam MCF-7 RELA KO)
CVCL_B9B4 (Abcam MCF-7 REST KO)CVCL_B9B5 (Abcam MCF-7 RET KO)CVCL_B9B6 (Abcam MCF-7 RICTOR KO)
CVCL_B9B7 (Abcam MCF-7 RNF2 KO)CVCL_B9B8 (Abcam MCF-7 ROS1 KO)CVCL_D2H6 (Abcam MCF-7 RPS6KA1 KO)
CVCL_B9B9 (Abcam MCF-7 RPS6KA3 KO)CVCL_B9BA (Abcam MCF-7 RSF1 KO)CVCL_B9BB (Abcam MCF-7 RSPO2 KO)
CVCL_B9BC (Abcam MCF-7 RUNX1 KO)CVCL_D2H7 (Abcam MCF-7 RUNX3 KO)CVCL_D2H8 (Abcam MCF-7 S100A8 KO)
CVCL_B9BD (Abcam MCF-7 SALL4 KO)CVCL_B9BE (Abcam MCF-7 SCARB2 KO)CVCL_B9BF (Abcam MCF-7 SETD7 KO)
CVCL_B9BG (Abcam MCF-7 SIRPA KO)CVCL_B9BH (Abcam MCF-7 SIRT1 KO)CVCL_D2H9 (Abcam MCF-7 SIRT2 KO)
CVCL_D2HA (Abcam MCF-7 SIRT6 KO)CVCL_B9BI (Abcam MCF-7 SMAD2 KO)CVCL_B9BJ (Abcam MCF-7 SMAD3 KO)
CVCL_B9BK (Abcam MCF-7 SMAD4 KO)CVCL_B9BL (Abcam MCF-7 SMARCA1 KO)CVCL_B9BM (Abcam MCF-7 SMARCA4 KO)
CVCL_B9BN (Abcam MCF-7 SMARCC1 KO)CVCL_B9BP (Abcam MCF-7 SMARCD3 KO)CVCL_B9BQ (Abcam MCF-7 SOS1 KO)
CVCL_B9BR (Abcam MCF-7 SOX2 KO)CVCL_B9BS (Abcam MCF-7 SP1 KO)CVCL_D2HB (Abcam MCF-7 SPI1 KO)
CVCL_B9BT (Abcam MCF-7 SPN KO)CVCL_B9BU (Abcam MCF-7 SPP1 KO)CVCL_B9BV (Abcam MCF-7 SRC KO)
CVCL_B9BW (Abcam MCF-7 SS18 KO)CVCL_B9BX (Abcam MCF-7 STAG2 KO)CVCL_B9BY (Abcam MCF-7 STAT1 KO)
CVCL_B9BZ (Abcam MCF-7 STAT3 KO)CVCL_D2HC (Abcam MCF-7 STAT5B KO)CVCL_B9C0 (Abcam MCF-7 STAT6 KO)
CVCL_B9C1 (Abcam MCF-7 STING1 KO)CVCL_B9C2 (Abcam MCF-7 STK11 KO)CVCL_B9C3 (Abcam MCF-7 SUFU KO)
CVCL_B9C4 (Abcam MCF-7 TACSTD2 KO)CVCL_B9C5 (Abcam MCF-7 TAFFAZIN KO)CVCL_D2HD (Abcam MCF-7 TDO2 KO)
CVCL_B9C6 (Abcam MCF-7 TET2 KO)CVCL_B9C7 (Abcam MCF-7 TFF3 KO)CVCL_B9C8 (Abcam MCF-7 TGFB1 KO)
CVCL_B9C9 (Abcam MCF-7 TGFBR2 KO)CVCL_D2HE (Abcam MCF-7 TIA1 KO)CVCL_B0ZZ (Abcam MCF-7 TLE1 KO)
CVCL_D2HF (Abcam MCF-7 TNFRSF17 KO)CVCL_D2HG (Abcam MCF-7 TNFRSF18 KO)CVCL_D2HH (Abcam MCF-7 TNFRSF4 KO)
CVCL_D2HI (Abcam MCF-7 TNFRSF8 KO)CVCL_D2HJ (Abcam MCF-7 TNFRSF9 KO)CVCL_B9CA (Abcam MCF-7 TNFSF11 KO)
CVCL_B9CB (Abcam MCF-7 TP53 KO)CVCL_B9CC (Abcam MCF-7 TP63 KO)CVCL_B1A0 (Abcam MCF-7 TPBG KO)
CVCL_D2HK (Abcam MCF-7 TRAF1 KO)CVCL_B9CD (Abcam MCF-7 TSC1 KO)CVCL_B9CE (Abcam MCF-7 TSC2 KO)
CVCL_D2HL (Abcam MCF-7 UBB KO)CVCL_B9CF (Abcam MCF-7 USP8 KO)CVCL_D2HM (Abcam MCF-7 VDR KO)
CVCL_D2HN (Abcam MCF-7 VEGFA KO)CVCL_B9CG (Abcam MCF-7 WRN KO)CVCL_D2HP (Abcam MCF-7 WT1 KO)
CVCL_B9CH (Abcam MCF-7 WWTR1 KO)CVCL_B9CI (Abcam MCF-7 XPC KO)CVCL_D1UY (Abcam MCF-7 XPO1 KO)
CVCL_B9CJ (Abcam MCF-7 YAP1 KO)CVCL_B9CK (Abcam MCF-7 ZBTB16 KO)CVCL_B9CL (Abcam MCF-7 ZEB1 KO)
CVCL_X007 (hTERT-EEC-B37)CVCL_2094 (KPL-1)CVCL_0404 (M7TS90)
CVCL_YX80 (MCF-7 A2)CVCL_C8MT (MCF-7 AC1)CVCL_ZZ17 (MCF-7 Ad75)
CVCL_ZZ18 (MCF-7 AdP500)CVCL_4Y65 (MCF-7 clone 33)CVCL_HA11 (MCF-7 eGFP-CEBPG)
CVCL_HA12 (MCF-7 eGFP-E2F4)CVCL_HA13 (MCF-7 eGFP-ELF1)CVCL_HA14 (MCF-7 eGFP-GABPA)
CVCL_HA15 (MCF-7 eGFP-GTF2E2)CVCL_HA16 (MCF-7 eGFP-HBP1)CVCL_HA17 (MCF-7 eGFP-KLF4)
CVCL_HA18 (MCF-7 eGFP-KLF9)CVCL_HA19 (MCF-7 eGFP-ZNF148)CVCL_ZZ19 (MCF-7 Ida6)
CVCL_UU87 (MCF-7 M13)CVCL_UU88 (MCF-7 M21)CVCL_UU89 (MCF-7 M27)
CVCL_LB51 (MCF-7 MX20)CVCL_LB50 (MCF-7 MX8)CVCL_B7K1 (MCF-7 PRODH KO)
CVCL_WK73 (MCF-7 R27)CVCL_IU96 (MCF-7 RR1)CVCL_IU97 (MCF-7 RR2)
CVCL_RA89 (MCF-7 shPARG)CVCL_YJ25 (MCF-7 shWDR12-4)CVCL_S030 (MCF-7 SimpleCell O-GalNAc)
CVCL_A4AQ (MCF-7 Tam1)CVCL_IU98 (MCF-7 TKi-R)CVCL_A8P5 (MCF-7 TTE-MBD2)
CVCL_ZZ20 (MCF-7 Tx200)CVCL_ZZ21 (MCF-7 Tx8)CVCL_4Y54 (MCF-7-2a)
CVCL_R954 (MCF-7-BAG)CVCL_4V96 (MCF-7-EpiR)CVCL_5I64 (MCF-7-FLV1000)
CVCL_J259 (MCF-7-Luc)CVCL_5J35 (MCF-7-luc-F5)CVCL_5J04 (MCF-7-Red-Fluc)
CVCL_4V97 (MCF-7-TaxR)CVCL_DC70 (MCF-7.5C)CVCL_0412 (MCF-7/2a)
CVCL_4V53 (MCF-7/4-HC)CVCL_4V44 (MCF-7/5-23)CVCL_W972 (MCF-7/6)
CVCL_4Y46 (MCF-7/AdrVp)CVCL_W971 (MCF-7/AZ)CVCL_ZZ40 (MCF-7/BCRP)
CVCL_GX99 (MCF-7/C4-12)CVCL_4D03 (MCF-7/CG-4)CVCL_4D04 (MCF-7/CG-5)
CVCL_HA20 (MCF-7/E2F1)CVCL_M439 (MCF-7/E6)CVCL_C5RU (MCF-7/F)
CVCL_5J37 (MCF-7/GFP)CVCL_0U80 (MCF-7/HER2-18)CVCL_5J36 (MCF-7/Luc)
CVCL_9579 (MCF-7/LY2)CVCL_Z704 (MCF-7/MDD2)CVCL_Z705 (MCF-7/MN1)
CVCL_B7P7 (MCF-7/PacR)CVCL_C5RS (MCF-7/PTX)CVCL_4V43 (MCF-7/RTx6)
CVCL_K235 (MCF-7/RU58R-1)CVCL_1D47 (MCF-7/S0.5)CVCL_WK28 (MCF-7/S7)
CVCL_AS09 (MCF-7/S9)CVCL_C0CU (MCF-7/SB-T-0035R)CVCL_IJ26 (MCF-7/TAX)
CVCL_M355 (MCF-7/Taxol)CVCL_4V42 (MCF-7/TPT300)CVCL_DR99 (MCF-7/Twist)
CVCL_2Z97 (MCF-7/VD(R))CVCL_5I65 (MCF-7/VP)CVCL_4Y53 (MCF-7:2A)
CVCL_9580 (MCF-7aro)CVCL_6860 (MCF-7B)CVCL_2Z98 (MCF-7D3Res)
CVCL_0088 (MCF-7L)CVCL_6672 (MCF-7M)CVCL_6673 (MCF-7N)
CVCL_Y493 (MCF-7R)CVCL_9V74 (MCF-hGH)CVCL_4Y47 (MCF/MX)
CVCL_M373 (MCF3B)CVCL_1D32 (MCF7 AREc32)CVCL_A4CH (MCF7 dCas9-KRAB)
CVCL_DF45 (MCF7 NucLight Green)CVCL_DF46 (MCF7 NucLight Red)CVCL_V357 (MCF7 Tet-Off)
CVCL_KU37 (MCF7 Tet-Off advanced)CVCL_V332 (MCF7 Tet-On)CVCL_KU45 (MCF7 Tet-On Advanced)
CVCL_V358 (MCF7 tTS)CVCL_3397 (MCF7-382)CVCL_3398 (MCF7-422)
CVCL_3399 (MCF7-432)CVCL_3400 (MCF7-488X1)CVCL_3401 (MCF7-490X1)
CVCL_3402 (MCF7-492X1)CVCL_4V66 (MCF7-AFA[r])CVCL_VH35 (MCF7-B7-TS)
CVCL_XD68 (MCF7-Cas9-542)CVCL_XD69 (MCF7-Cas9-543)CVCL_XD70 (MCF7-Cas9-544)
CVCL_B5PF (MCF7-FGFR1)CVCL_VR08 (MCF7-h14)CVCL_YX84 (MCF7-LTED)
CVCL_C8Y8 (MCF7-Luc)CVCL_A4CI (MCF7-Luc2)CVCL_C3ID (MCF7-parkin clone 11)
CVCL_C3IB (MCF7-parkin clone 5)CVCL_C3IC (MCF7-parkin clone 7)CVCL_EG55 (MCF7-TamR)
CVCL_0413 (MCF7/BUS)CVCL_EQ28 (MCF7/c)CVCL_C9CD (MCF7/Cas9 AAVS1)
CVCL_M437 (MCF7/D40)CVCL_DP49 (MCF7/MIII)CVCL_M438 (MCF7/Mitox)
CVCL_B7JP (MCF7/TROP2-KO)CVCL_EQ29 (MCF7/XBP1)CVCL_C4M9 (MCF-7(DOX/R))
CVCL_0415 (MCF7mp53)CVCL_R955 (MCS-2 [Human breast carcinoma])CVCL_WI91 (MELN)
CVCL_4Y56 (MVLN)CVCL_6571 (VM7Luc4E2)
Originate from same individual CVCL_N481 ! Hs 631.T
Sex of cell Female
Age at sampling 69Y
Category Cancer cell line
STR profile Source(s): AddexBio; ATCC; CCRID; CLS; Cosmic-CLP; DSMZ; ECACC; Genomics_Center_BCF_Technion; JCRB; KCLB; DOI=10.4172/2157-7145.S2-005; PubMed=11416159; PubMed=17254797; PubMed=19372543; PubMed=25321415; PubMed=25877200; PubMed=27456714; PubMed=28889351; RCB; TKG

Markers:
AmelogeninX
CSF1PO10
D1S165615.3
D2S44110,14
D2S133821,23
D3S135816
D5S81811,12 (AddexBio; ATCC; CCRID; Cosmic-CLP; DSMZ; ECACC; Genomics_Center_BCF_Technion; JCRB; KCLB; DOI=10.4172/2157-7145.S2-005; PubMed=17254797; PubMed=19372543; PubMed=25321415; PubMed=25877200; PubMed=27456714; PubMed=28889351; RCB; TKG)
12 (CLS)
D6S104312,18
D7S8208,9
D8S117910,14
D10S124814
D12S39118,20
D13S31711
D16S53911,12
D18S5114
D19S43313,14
D21S1130
D22S104515,16
FGA23,24,25 (CCRID; DSMZ)
23,25 (CLS; Genomics_Center_BCF_Technion; PubMed=17254797; PubMed=19372543; PubMed=25877200)
Penta D12
Penta E7,12
TH016
TPOX9,12
vWA14,15

Run an STR similarity search on this cell line
Web pages https://en.wikipedia.org/wiki/MCF-7
http://www.mcf7.com/
https://www.atcc.org/en/support/technical-support/faqs/htb-22-growth-and-morphology
http://www.cells-talk.com/index.php/page/copelibrary?key=MCF-7
https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm
https://web.archive.org/web/20210320165028/https://physics.cancer.gov/docs/bioresource/breast/NCI-PBCF-HTB22_MCF7_SOP-508.pdf
https://strap.nci.nih.gov/celline_detail.php?sample_id=1
https://www.proteinatlas.org/learn/cellines
http://141.61.102.20/mxdb/project/show/9191407937500
http://www.genboree.org/java-bin/MCF7/index.jsp?isPublic=Yes
https://www.cellosaurus.org/pawefish/BreastCellLineDescriptions/mcf7.htm
http://dpsc.ccbr.utoronto.ca/cancer/get_cellline.pl?cellline=MCF7
http://genome.ucsc.edu/ENCODE/protocols/cell/human/MCF-7_Crawford_protocol.pdf
https://lincs.hms.harvard.edu/resources/reagents/icbp43/
https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/m/cell-lines-detail-36.html
https://www.synapse.org/#!Synapse:syn2346643/wiki/62255
https://www.phe-culturecollections.org.uk/media/130237/mcf7-cell-line-profile.pdf
https://tcpaportal.org/mclp/
Publications

PubMed=4353636; DOI=10.1016/S0021-9258(19)43537-0
Brooks S.C. Jr., Locke E.R., Soule H.D.
Estrogen receptor in a human cell line (MCF-7) from breast carcinoma.
J. Biol. Chem. 248:6251-6253(1973)

PubMed=4357757; DOI=10.1093/jnci/51.5.1409
Soule H.D., Vazguez J., Long A., Albert S., Brennan M.
A human cell line from a pleural effusion derived from a breast carcinoma.
J. Natl. Cancer Inst. 51:1409-1416(1973)

PubMed=4138511; DOI=10.1038/252247a0
McGrath C.M., Grant P.M., Soule H.D., Glancy T., Rich M.A.
Replication of oncornavirus-like particle in human breast carcinoma cell line, MCF-7.
Nature 252:247-250(1974)

PubMed=1000504
Lippman M.E., Bolan G., Huff K.
The effects of estrogens and antiestrogens on hormone-responsive human breast cancer in long-term tissue culture.
Cancer Res. 36:4595-4601(1976)

PubMed=1000505
Lippman M.E., Bolan G., Huff K.
The effects of glucocorticoids and progesterone on hormone-responsive human breast cancer in long-term tissue culture.
Cancer Res. 36:4602-4609(1976)

PubMed=1000506
Lippman M.E., Bolan G., Huff K.
The effects of androgens and antiandrogens on hormone-responsive human breast cancer in long-term tissue culture.
Cancer Res. 36:4610-4618(1976)

PubMed=6935474; DOI=10.1093/jnci/66.2.239
Wright W.C., Daniels W.P., Fogh J.
Distinction of seventy-one cultured human tumor cell lines by polymorphic enzyme analysis.
J. Natl. Cancer Inst. 66:239-247(1981)

PubMed=7228867; DOI=10.1016/S0021-9258(19)69359-2
Nawata H., Bronzert D.A., Lippman M.E.
Isolation and characterization of a tamoxifen-resistant cell line derived from MCF-7 human breast cancer cells.
J. Biol. Chem. 256:5016-5021(1981)

PubMed=6582512; DOI=10.1073/pnas.81.2.568
Mattes M.J., Cordon-Cardo C., Lewis J.L. Jr., Old L.J., Lloyd K.O.
Cell surface antigens of human ovarian and endometrial carcinoma defined by mouse monoclonal antibodies.
Proc. Natl. Acad. Sci. U.S.A. 81:568-572(1984)

PubMed=3518877; DOI=10.3109/07357908609038260
Fogh J.
Human tumor lines for cancer research.
Cancer Invest. 4:157-184(1986)

PubMed=3702420; DOI=10.1016/0022-4731(86)90083-X
Devleeschouwer N., Olea-Serrano N., Leclercq G., Legros N., Heuson J.-C.
Induction of progesterone receptor in an estrogen, progesterone receptor-negative breast cancer cell line.
J. Steroid Biochem. 24:365-368(1986)

PubMed=3335022
Alley M.C., Scudiero D.A., Monks A., Hursey M.L., Czerwinski M.J., Fine D.L., Abbott B.J., Mayo J.G., Shoemaker R.H., Boyd M.R.
Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay.
Cancer Res. 48:589-601(1988)

PubMed=1911442; DOI=10.1016/0960-0760(91)90248-4
Wild M.J., Rudland P.S., Back D.J.
Metabolism of the oral contraceptive steroids ethynylestradiol and norgestimate by normal (Huma 7) and malignant (MCF-7 and ZR-75-1) human breast cells in culture.
J. Steroid Biochem. Mol. Biol. 39:535-543(1991)

DOI=10.1016/B978-0-12-333530-2.50009-5
Leibovitz A.
Cell lines from human breast.
(In) Atlas of human tumor cell lines; Hay R.J., Park J.-G., Gazdar A.F. (eds.); pp.161-184; Academic Press; New York (1994)

PubMed=7531416
Rostagno P., Moll J.-L., Birtwisle-Peyrottes I., Ettore F., Lagrange J.-L., Gioanni J., Caldani C.
Effects of tamoxifen on potential doubling time of human breast cancer cell line determined by image cytometry of double fluorescent BrdU and DNA labeling.
Anticancer Res. 14:2025-2032(1994)

PubMed=7842014; DOI=10.1038/ng1094-155
Guan X.-Y., Meltzer P.S., Dalton W.S., Trent J.M.
Identification of cryptic sites of DNA sequence amplification in human breast cancer by chromosome microdissection.
Nat. Genet. 8:155-161(1994)

PubMed=7498097; DOI=10.1289/ehp.95103844
Villalobos M., Olea N., Brotons J.A., Olea-Serrano M.F., Ruiz de Almodovar J.M., Pedraza V.
The E-screen assay: a comparison of different MCF7 cell stocks.
Environ. Health Perspect. 103:844-850(1995)

PubMed=8626706; DOI=10.1074/jbc.271.19.11477
Quinn K.A., Treston A.M., Unsworth E.J., Miller M.-J., Vos M., Grimley C., Battey J., Mulshine J.L., Cuttitta F.
Insulin-like growth factor expression in human cancer cell lines.
J. Biol. Chem. 271:11477-11483(1996)

PubMed=8824553; DOI=10.1002/(SICI)1097-0215(19960917)67:6<816::AID-IJC10>3.0.CO;2-#
Mullen P., Ritchie A., Langdon S.P., Miller W.R.
Effect of Matrigel on the tumorigenicity of human breast and ovarian carcinoma cell lines.
Int. J. Cancer 67:816-820(1996)

PubMed=9242427
Levenson A.S., Jordan V.C.
MCF-7: the first hormone-responsive breast cancer cell line.
Cancer Res. 57:3071-3078(1997)

PubMed=9488600; DOI=10.1007/s002800050744
Ma J.-G., Maliepaard M., Nooter K., Boersma A.W.M., Verweij J., Stoter G., Schellens J.H.M.
Synergistic cytotoxicity of cisplatin and topotecan or SN-38 in a panel of eight solid-tumor cell lines in vitro.
Cancer Chemother. Pharmacol. 41:307-316(1998)

PubMed=9671407; DOI=10.1038/sj.onc.1201814
Sweeney K.J., Swarbrick A., Sutherland R.L., Musgrove E.A.
Lack of relationship between CDK activity and G1 cyclin expression in breast cancer cells.
Oncogene 16:2865-2878(1998)

PubMed=10381137; DOI=10.1016/s0304-3835(98)00270-5
Ohta H., Sakamoto H., Satoh K.
In vitro effects of gonadotropin-releasing hormone (GnRH) analogue on cancer cell sensitivity to cis-platinum.
Cancer Lett. 134:111-118(1998)

PubMed=10700174; DOI=10.1038/73432
Ross D.T., Scherf U., Eisen M.B., Perou C.M., Rees C., Spellman P.T., Iyer V.R., Jeffrey S.S., van de Rijn M., Waltham M.C., Pergamenschikov A., Lee J.C.F., Lashkari D., Shalon D., Myers T.G., Weinstein J.N., Botstein D., Brown P.O.
Systematic variation in gene expression patterns in human cancer cell lines.
Nat. Genet. 24:227-235(2000)

PubMed=10862037; DOI=10.1002/1098-2264(200007)28:3<308::AID-GCC9>3.0.CO;2-B
Kytola S., Rummukainen J., Nordgren A., Karhu R., Farnebo F., Isola J., Larsson C.
Chromosomal alterations in 15 breast cancer cell lines by comparative genomic hybridization and spectral karyotyping.
Genes Chromosomes Cancer 28:308-317(2000)

PubMed=10969801
Forozan F., Mahlamaki E.H., Monni O., Chen Y.-D., Veldman R., Jiang Y., Gooden G.C., Ethier S.P., Kallioniemi A., Kallioniemi O.-P.
Comparative genomic hybridization analysis of 38 breast cancer cell lines: a basis for interpreting complementary DNA microarray data.
Cancer Res. 60:4519-4525(2000)

PubMed=11044355; DOI=10.1054/bjoc.2000.1458
Davidson J.M., Gorringe K.L., Chin S.-F., Orsetti B., Besret C., Courtay-Cahen C., Roberts I., Theillet C., Caldas C., Edwards P.A.W.
Molecular cytogenetic analysis of breast cancer cell lines.
Br. J. Cancer 83:1309-1317(2000)

PubMed=11078910; DOI=10.1016/S0304-3835(00)00579-6
Lilling G., Hacohen H., Nordenberg J., Livnat T., Rotter V., Sidi Y.
Differential sensitivity of MCF-7 and LCC2 cells, to multiple growth inhibitory agents: possible relation to high bcl-2/bax ratio?
Cancer Lett. 161:27-34(2000)

PubMed=11292682; DOI=10.1096/fj.00-0527fje
Vassy J., Portet S., Beil M., Millot G., Fauvel-Lafeve F., Karniguian A., Gasset G., Irinopoulou T., Calvo F., Rigaut J.P., Schoevaert D.
The effect of weightlessness on cytoskeleton architecture and proliferation of human breast cancer cell line MCF-7.
FASEB J. 15:1104-1106(2001)

PubMed=11416159; DOI=10.1073/pnas.121616198
Masters J.R.W., Thomson J.A., Daly-Burns B., Reid Y.A., Dirks W.G., Packer P., Toji L.H., Ohno T., Tanabe H., Arlett C.F., Kelland L.R., Harrison M., Virmani A.K., Ward T.H., Ayres K.L., Debenham P.G.
Short tandem repeat profiling provides an international reference standard for human cell lines.
Proc. Natl. Acad. Sci. U.S.A. 98:8012-8017(2001)

PubMed=11789735; DOI=10.1309/4NCM-QJ9W-QM0J-6QJE
Rhodes A., Jasani B., Couturier J., McKinley M.J., Morgan J.M., Dodson A.R., Navabi H., Miller K.D., Balaton A.J.
A formalin-fixed, paraffin-processed cell line standard for quality control of immunohistochemical assay of HER-2/neu expression in breast cancer.
Am. J. Clin. Pathol. 117:81-89(2002)

PubMed=12353263; DOI=10.1002/gcc.10107
Popovici C., Basset C., Bertucci F., Orsetti B., Adelaide J., Mozziconacci M.-J., Conte N., Murati A., Ginestier C., Charafe-Jauffret E., Ethier S.P., Lafage-Pochitaloff M., Theillet C., Birnbaum D., Chaffanet M.
Reciprocal translocations in breast tumor cell lines: cloning of a t(3;20) that targets the FHIT gene.
Genes Chromosomes Cancer 35:204-218(2002)

PubMed=12661003; DOI=10.1002/gcc.10196
Seitz S., Wassmuth P., Plaschke J., Schackert H.K., Karsten U., Santibanez-Koref M.F., Schlag P.M., Scherneck S.
Identification of microsatellite instability and mismatch repair gene mutations in breast cancer cell lines.
Genes Chromosomes Cancer 37:29-35(2003)

PubMed=12775708; DOI=10.1074/jbc.M305226200
Martin L.-A., Farmer I., Johnston S.R.D., Ali S., Marshall C.J., Dowsett M.
Enhanced estrogen receptor (ER) alpha, ERBB2, and MAPK signal transduction pathways operate during the adaptation of MCF-7 cells to long term estrogen deprivation.
J. Biol. Chem. 278:30458-30468(2003)

PubMed=12800145; DOI=10.1002/gcc.10218
Adelaide J., Huang H.-E., Murati A., Alsop A.E., Orsetti B., Mozziconacci M.-J., Popovici C., Ginestier C., Letessier A., Basset C., Courtay-Cahen C., Jacquemier J., Theillet C., Birnbaum D., Edwards P.A.W., Chaffanet M.
A recurrent chromosome translocation breakpoint in breast and pancreatic cancer cell lines targets the neuregulin/NRG1 gene.
Genes Chromosomes Cancer 37:333-345(2003)

PubMed=15002416; DOI=10.1016/S0273-1177(03)90400-5
Vassy J., Portet S., Beil M., Millot G., Fauvel-Lafeve F., Gasset G., Schoevaert-Brossault D.
Weightlessness acts on human breast cancer cell line MCF-7.
Adv. Space Res. 32:1595-1603(2003)

PubMed=15361840; DOI=10.1038/sj.onc.1207966
Usary J., Llaca V., Karaca G., Presswala S., Karaca M., He X.-P., Langerod A., Karesen R., Oh D.S., Dressler L.G., Lonning P.E., Strausberg R.L., Chanock S.J., Borresen-Dale A.-L., Perou C.M.
Mutation of GATA3 in human breast tumors.
Oncogene 23:7669-7678(2004)

PubMed=15677628; DOI=10.1093/carcin/bgi032
Gorringe K.L., Chin S.-F., Pharoah P.D.P., Staines J.M., Oliveira C., Edwards P.A.W., Caldas C.
Evidence that both genetic instability and selection contribute to the accumulation of chromosome alterations in cancer.
Carcinogenesis 26:923-930(2005)

PubMed=15748285; DOI=10.1186/1479-5876-3-11
Adams S., Robbins F.-M., Chen D., Wagage D., Holbeck S.L., Morse H.C. III, Stroncek D., Marincola F.M.
HLA class I and II genotype of the NCI-60 cell lines.
J. Transl. Med. 3:11.1-11.8(2005)

PubMed=15767549; DOI=10.1158/1535-7163.MCT-04-0234
Nakatsu N., Yoshida Y., Yamazaki K., Nakamura T., Dan S., Fukui Y., Yamori T.
Chemosensitivity profile of cancer cell lines and identification of genes determining chemosensitivity by an integrated bioinformatical approach using cDNA arrays.
Mol. Cancer Ther. 4:399-412(2005)

PubMed=15900046; DOI=10.1093/jnci/dji133
Mashima T., Oh-hara T., Sato S., Mochizuki M., Sugimoto Y., Yamazaki K., Hamada J.-i., Tada M., Moriuchi T., Ishikawa Y., Kato Y., Tomoda H., Yamori T., Tsuruo T.
p53-defective tumors with a functional apoptosome-mediated pathway: a new therapeutic target.
J. Natl. Cancer Inst. 97:765-777(2005)

PubMed=16142302; DOI=10.3892/ijo.27.4.881
de Longueville F., Lacroix M., Barbuto A.-M., Bertholet V., Gallo D., Larsimont D., Marcq L., Zammatteo N., Boffe S., Leclercq G., Remacle J.
Molecular characterization of breast cancer cell lines by a low-density microarray.
Int. J. Oncol. 27:881-892(2005)

PubMed=16397213; DOI=10.1158/0008-5472.CAN-05-2853
Elstrodt F., Hollestelle A., Nagel J.H.A., Gorin M., Wasielewski M., van den Ouweland A., Merajver S.D., Ethier S.P., Schutte M.
BRCA1 mutation analysis of 41 human breast cancer cell lines reveals three new deleterious mutants.
Cancer Res. 66:41-45(2006)

PubMed=16417655; DOI=10.1186/bcr1370
Shadeo A., Lam W.L.
Comprehensive copy number profiles of breast cancer cell model genomes.
Breast Cancer Res. 8:R9.1-R9.14(2006)

PubMed=16541312; DOI=10.1007/s10549-006-9186-z
Wasielewski M., Elstrodt F., Klijn J.G.M., Berns E.M.J.J., Schutte M.
Thirteen new p53 gene mutants identified among 41 human breast cancer cell lines.
Breast Cancer Res. Treat. 99:97-101(2006)

PubMed=17088437; DOI=10.1158/1535-7163.MCT-06-0433
Ikediobi O.N., Davies H., Bignell G.R., Edkins S., Stevens C., O'Meara S., Santarius T., Avis T., Barthorpe S., Brackenbury L., Buck G., Butler A.P., Clements J., Cole J., Dicks E., Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J., Hunter C., Jenkinson A., Jones D., Kosmidou V., Lugg R., Menzies A., Mironenko T., Parker A., Perry J., Raine K.M., Richardson D., Shepherd R., Small A., Smith R., Solomon H., Stephens P.J., Teague J.W., Tofts C., Varian J., Webb T., West S., Widaa S., Yates A., Reinhold W.C., Weinstein J.N., Stratton M.R., Futreal P.A., Wooster R.
Mutation analysis of 24 known cancer genes in the NCI-60 cell line set.
Mol. Cancer Ther. 5:2606-2612(2006)

PubMed=17157791; DOI=10.1016/j.ccr.2006.10.008
Neve R.M., Chin K., Fridlyand J., Yeh J., Baehner F.L., Fevr T., Clark L., Bayani N., Coppe J.-P., Tong F., Speed T., Spellman P.T., DeVries S., Lapuk A., Wang N.J., Kuo W.-L., Stilwell J.L., Pinkel D., Albertson D.G., Waldman F.M., McCormick F., Dickson R.B., Johnson M.D., Lippman M.E., Ethier S.P., Gazdar A.F., Gray J.W.
A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes.
Cancer Cell 10:515-527(2006)

PubMed=17254797; DOI=10.1016/j.biologicals.2006.10.001
Azari S., Ahmadi N., Tehrani M.J., Shokri F.
Profiling and authentication of human cell lines using short tandem repeat (STR) loci: report from the National Cell Bank of Iran.
Biologicals 35:195-202(2007)

PubMed=17334996; DOI=10.1002/gcc.20438
Jonsson G., Staaf J., Olsson E., Heidenblad M., Vallon-Christersson J., Osoegawa K., de Jong P.J., Oredsson S.M., Ringner M., Hoglund M., Borg A.
High-resolution genomic profiles of breast cancer cell lines assessed by tiling BAC array comparative genomic hybridization.
Genes Chromosomes Cancer 46:543-558(2007)

PubMed=18516279; DOI=10.1016/j.molonc.2007.02.004
Kenny P.A., Lee G.Y., Myers C.A., Neve R.M., Semeiks J.R., Spellman P.T., Lorenz K., Lee E.H., Barcellos-Hoff M.H., Petersen O.W., Gray J.W., Bissell M.J.
The morphologies of breast cancer cell lines in three-dimensional assays correlate with their profiles of gene expression.
Mol. Oncol. 1:84-96(2007)

PubMed=18386134; DOI=10.1007/s10585-008-9169-z
Hughes L., Malone C., Chumsri S., Burger A.M., McDonnell S.
Characterisation of breast cancer cell lines and establishment of a novel isogenic subclone to study migration, invasion and tumourigenicity.
Clin. Exp. Metastasis 25:549-557(2008)

PubMed=19372543; DOI=10.1158/1535-7163.MCT-08-0921
Lorenzi P.L., Reinhold W.C., Varma S., Hutchinson A.A., Pommier Y., Chanock S.J., Weinstein J.N.
DNA fingerprinting of the NCI-60 cell line panel.
Mol. Cancer Ther. 8:713-724(2009)

PubMed=19582160; DOI=10.1371/journal.pone.0006146
Kao J., Salari K., Bocanegra M., Choi Y.-L., Girard L., Gandhi J., Kwei K.A., Hernandez-Boussard T., Wang P., Gazdar A.F., Minna J.D., Pollack J.R.
Molecular profiling of breast cancer cell lines defines relevant tumor models and provides a resource for cancer gene discovery.
PLoS ONE 4:E6146-E6146(2009)

PubMed=19727395; DOI=10.1371/journal.pone.0006888
Wadlow R.C., Wittner B.S., Finley S.A., Bergquist H., Upadhyay R., Finn S.P., Loda M., Mahmood U., Ramaswamy S.
Systems-level modeling of cancer-fibroblast interaction.
PLoS ONE 4:E6888-E6888(2009)

CLPUB00423
Morrison B.J.
Breast cancer stem cells: tumourspheres and implications for therapy.
Thesis PhD (2010), Griffith University, Australia

DOI=10.1186/gb-2010-11-s1-p8
Chiang Y.-S., Seng L.Y., Lin Y.-Y., Chen S.-H., Su Y.-C., Chen T.-H., Kuo H.-C., Chen C.-H., Chiu K.-P.
Single cell transcriptome analysis upon MCF-7 breast cancer.
Genome Biol. 11 Suppl. 1:P8-P8(2010)

PubMed=19593635; DOI=10.1007/s10549-009-0460-8
Hollestelle A., Nagel J.H.A., Smid M., Lam S., Elstrodt F., Wasielewski M., Ng S.S., French P.J., Peeters J.K., Rozendaal M.J., Riaz M., Koopman D.G., ten Hagen T.L.M., de Leeuw B.H.C.G.M., Zwarthoff E.C., Teunisse A., van der Spek P.J., Klijn J.G.M., Dinjens W.N.M., Ethier S.P., Clevers H.C., Jochemsen A.G., den Bakker M.A., Foekens J.A., Martens J.W.M., Schutte M.
Distinct gene mutation profiles among luminal-type and basal-type breast cancer cell lines.
Breast Cancer Res. Treat. 121:53-64(2010)

PubMed=20070913; DOI=10.1186/1471-2407-10-15
Tsuji K., Kawauchi S., Saito S., Furuya T., Ikemoto K., Nakao M., Yamamoto S., Oka M., Hirano T., Sasaki K.
Breast cancer cell lines carry cell line-specific genomic alterations that are distinct from aberrations in breast cancer tissues: comparison of the CGH profiles between cancer cell lines and primary cancer tissues.
BMC Cancer 10:15.1-15.10(2010)

PubMed=20164919; DOI=10.1038/nature08768
Bignell G.R., Greenman C.D., Davies H., Butler A.P., Edkins S., Andrews J.M., Buck G., Chen L., Beare D., Latimer C., Widaa S., Hinton J., Fahey C., Fu B.-Y., Swamy S., Dalgliesh G.L., Teh B.T., Deloukas P., Yang F.-T., Campbell P.J., Futreal P.A., Stratton M.R.
Signatures of mutation and selection in the cancer genome.
Nature 463:893-898(2010)

PubMed=20215515; DOI=10.1158/0008-5472.CAN-09-3458
Rothenberg S.M., Mohapatra G., Rivera M.N., Winokur D., Greninger P., Nitta M., Sadow P.M., Sooriyakumar G., Brannigan B.W., Ulman M.J., Perera R.M., Wang R., Tam A., Ma X.-J., Erlander M., Sgroi D.C., Rocco J.W., Lingen M.W., Cohen E.E.W., Louis D.N., Settleman J., Haber D.A.
A genome-wide screen for microdeletions reveals disruption of polarity complex genes in diverse human cancers.
Cancer Res. 70:2158-2164(2010)

DOI=10.4172/2157-7145.S2-005
Fang R.-X., Shewale J.G., Nguyen V.T., Cardoso H., Swerdel M., Hart R.P., Furtado M.R.
STR profiling of human cell lines: challenges and possible solutions to the growing problem.
J. Forensic Res. 2 Suppl. 2:5-5(2011)

PubMed=21247443; DOI=10.1186/gb-2011-12-1-r6
Edgren H., Murumagi A., Kangaspeska S., Nicorici D., Hongisto V., Kleivi K., Rye I.H., Nyberg S., Wolf M., Borresen-Dale A.-L., Kallioniemi O.-P.
Identification of fusion genes in breast cancer by paired-end RNA-sequencing.
Genome Biol. 12:R6.1-R6.13(2011)

PubMed=21378333
Ford C.H.J., Al-Bader M., Al-Ayadhi B., Francis I.
Reassessment of estrogen receptor expression in human breast cancer cell lines.
Anticancer Res. 31:521-527(2011)

PubMed=22068913; DOI=10.1073/pnas.1111840108
Gillet J.-P., Calcagno A.M., Varma S., Marino M., Green L.J., Vora M.I., Patel C., Orina J.N., Eliseeva T.A., Singal V., Padmanabhan R., Davidson B., Ganapathi R., Sood A.K., Rueda B.R., Ambudkar S.V., Gottesman M.M.
Redefining the relevance of established cancer cell lines to the study of mechanisms of clinical anti-cancer drug resistance.
Proc. Natl. Acad. Sci. U.S.A. 108:18708-18713(2011)

PubMed=22278370; DOI=10.1074/mcp.M111.014050
Geiger T., Wehner A., Schaab C., Cox J., Mann M.
Comparative proteomic analysis of eleven common cell lines reveals ubiquitous but varying expression of most proteins.
Mol. Cell. Proteomics 11:M111.014050-M111.014050(2012)

PubMed=22336246; DOI=10.1016/j.bmc.2012.01.017
Kong D.-X., Yamori T.
JFCR39, a panel of 39 human cancer cell lines, and its application in the discovery and development of anticancer drugs.
Bioorg. Med. Chem. 20:1947-1951(2012)

PubMed=22347499; DOI=10.1371/journal.pone.0031628
Ruan X.-Y., Kocher J.-P.A., Pommier Y., Liu H.-F., Reinhold W.C.
Mass homozygotes accumulation in the NCI-60 cancer cell lines as compared to HapMap trios, and relation to fragile site location.
PLoS ONE 7:E31628-E31628(2012)

PubMed=22384151; DOI=10.1371/journal.pone.0032096
Lee J.-S., Kim Y.K., Kim H.J., Hajar S., Tan Y.L., Kang N.-Y., Ng S.H., Yoon C.N., Chang Y.-T.
Identification of cancer cell-line origins using fluorescence image-based phenomic screening.
PLoS ONE 7:E32096-E32096(2012)

PubMed=22414580; DOI=10.1158/0008-5472.CAN-11-3711
Geiger T., Madden S.F., Gallagher W.M., Cox J., Mann M.
Proteomic portrait of human breast cancer progression identifies novel prognostic markers.
Cancer Res. 72:2428-2439(2012)

PubMed=22460905; DOI=10.1038/nature11003
Barretina J.G., Caponigro G., Stransky N., Venkatesan K., Margolin A.A., Kim S., Wilson C.J., Lehar J., Kryukov G.V., Sonkin D., Reddy A., Liu M., Murray L., Berger M.F., Monahan J.E., Morais P., Meltzer J., Korejwa A., Jane-Valbuena J., Mapa F.A., Thibault J., Bric-Furlong E., Raman P., Shipway A., Engels I.H., Cheng J., Yu G.-Y.K., Yu J.-J., Aspesi P. Jr., de Silva M., Jagtap K., Jones M.D., Wang L., Hatton C., Palescandolo E., Gupta S., Mahan S., Sougnez C., Onofrio R.C., Liefeld T., MacConaill L.E., Winckler W., Reich M., Li N.-X., Mesirov J.P., Gabriel S.B., Getz G., Ardlie K., Chan V., Myer V.E., Weber B.L., Porter J., Warmuth M., Finan P., Harris J.L., Meyerson M.L., Golub T.R., Morrissey M.P., Sellers W.R., Schlegel R., Garraway L.A.
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity.
Nature 483:603-607(2012)

PubMed=22585861; DOI=10.1158/2159-8290.CD-11-0224
Marcotte R., Brown K.R., Suarez Saiz F.J., Sayad A., Karamboulas K., Krzyzanowski P.M., Sircoulomb F., Medrano M., Fedyshyn Y., Koh J.L.Y., van Dyk D., Fedyshyn B., Luhova M., Brito G.C., Vizeacoumar F.J., Vizeacoumar F.S., Datti A., Kasimer D., Buzina A., Mero P., Misquitta C., Normand J., Haider M., Ketela T., Wrana J.L., Rottapel R., Neel B.G., Moffat J.
Essential gene profiles in breast, pancreatic, and ovarian cancer cells.
Cancer Discov. 2:172-189(2012)

PubMed=22628656; DOI=10.1126/science.1218595
Jain M., Nilsson R., Sharma S., Madhusudhan N., Kitami T., Souza A.L., Kafri R., Kirschner M.W., Clish C.B., Mootha V.K.
Metabolite profiling identifies a key role for glycine in rapid cancer cell proliferation.
Science 336:1040-1044(2012)

PubMed=23285151; DOI=10.1371/journal.pone.0052692
Morrison B.J., Hastie M.L., Grewal Y.S., Bruce Z.C., Schmidt C., Reynolds B.A., Gorman J.J., Lopez J.A.
Proteomic comparison of MCF-7 tumoursphere and monolayer cultures.
PLoS ONE 7:E52692-E52692(2012)

CLPUB00336
Crane A., Brennan M., Naebers R.
Catherine Frances Mallon's 'immortal cells'.
IHM Arch. Notes 4:2.1-2.1(2013)

PubMed=23234512; DOI=10.1021/pr300898u
Segura V., Medina-Aunon J.A., Guruceaga E., Gharbi S.I., Gonzalez-Tejedo C., Sanchez del Pino M.M., Canals F., Fuentes M., Casal J.I., Martinez-Bartolome S., Elortza F., Mato J.M., Arizmendi J.M., Abian J., Oliveira E., Gil C., Vivanco F., Blanco F., Albar J.P., Corrales F.J.
Spanish human proteome project: dissection of chromosome 16.
J. Proteome Res. 12:112-122(2013)

PubMed=23325432; DOI=10.1101/gr.147942.112
Varley K.E., Gertz J., Bowling K.M., Parker S.L., Reddy T.E., Pauli-Behn F., Cross M.K., Williams B.A., Stamatoyannopoulos J.A., Crawford G.E., Absher D.M., Wold B.J., Myers R.M.
Dynamic DNA methylation across diverse human cell lines and tissues.
Genome Res. 23:555-567(2013)

PubMed=23601657; DOI=10.1186/bcr3415
Riaz M., van Jaarsveld M.T.M., Hollestelle A., Prager-van der Smissen W.J.C., Heine A.A.J., Boersma A.W.M., Liu J.-J., Helmijr J.C.A., Ozturk B., Smid M., Wiemer E.A.C., Foekens J.A., Martens J.W.M.
miRNA expression profiling of 51 human breast cancer cell lines reveals subtype and driver mutation-specific miRNAs.
Breast Cancer Res. 15:R33.1-R33.17(2013)

PubMed=23671654; DOI=10.1371/journal.pone.0063056
Lu Y.-H., Soong T.D., Elemento O.
A novel approach for characterizing microsatellite instability in cancer cells.
PLoS ONE 8:E63056-E63056(2013)

PubMed=23770244; DOI=10.1016/j.celrep.2013.05.024
Wierer M., Verde G., Pisano P., Molina H., Font-Mateu J., Di Croce L., Beato M.
PLK1 signaling in breast cancer cells cooperates with estrogen receptor-dependent gene transcription.
Cell Rep. 3:2021-2032(2013)

PubMed=23856246; DOI=10.1158/0008-5472.CAN-12-3342
Abaan O.D., Polley E.C., Davis S.R., Zhu Y.-L.J., Bilke S., Walker R.L., Pineda M.A., Gindin Y., Jiang Y., Reinhold W.C., Holbeck S.L., Simon R.M., Doroshow J.H., Pommier Y., Meltzer P.S.
The exomes of the NCI-60 panel: a genomic resource for cancer biology and systems pharmacology.
Cancer Res. 73:4372-4382(2013)

PubMed=23868472; DOI=10.1038/ncomms3175
Johansson H.J., Sanchez B.C., Mundt F., Forshed J., Kovacs A., Panizza E., Hultin-Rosenberg L., Lundgren B., Martens U., Mathe G., Yakhini Z., Helou K., Krawiec K., Kanter L., Hjerpe A., Stal O., Linderholm B.K., Lehtio J.
Retinoic acid receptor alpha is associated with tamoxifen resistance in breast cancer.
Nat. Commun. 4:2175.1-2175.10(2013)

PubMed=23933261; DOI=10.1016/j.celrep.2013.07.018
Moghaddas Gholami A., Hahne H., Wu Z.-X., Auer F.J., Meng C., Wilhelm M., Kuster B.
Global proteome analysis of the NCI-60 cell line panel.
Cell Rep. 4:609-620(2013)

PubMed=24009699; DOI=10.1371/journal.pone.0072704
Liu X., Nie H., Zhang Y.-B., Yao Y.-F., Maitikabili A., Qu Y.-P., Shi S.-L., Chen C.-Y., Li Y.
Cell surface-specific N-glycan profiling in breast cancer.
PLoS ONE 8:E72704-E72704(2013)

PubMed=24094812; DOI=10.1016/j.ccr.2013.08.020
Timmerman L.A., Holton T., Yuneva M., Louie R.J., Padro M., Daemen A., Hu M., Chan D.A., Ethier S.P., van 't Veer L.J., Polyak K., McCormick F., Gray J.W.
Glutamine sensitivity analysis identifies the xCT antiporter as a common triple-negative breast tumor therapeutic target.
Cancer Cell 24:450-465(2013)

PubMed=24162158; DOI=10.1007/s10549-013-2743-3
Prat A., Karginova O., Parker J.S., Fan C., He X.-P., Bixby L.M., Harrell J.C., Roman E., Adamo B., Troester M.A., Perou C.M.
Characterization of cell lines derived from breast cancers and normal mammary tissues for the study of the intrinsic molecular subtypes.
Breast Cancer Res. Treat. 142:237-255(2013)

PubMed=24176112; DOI=10.1186/gb-2013-14-10-r110
Daemen A., Griffith O.L., Heiser L.M., Wang N.J., Enache O.M., Sanborn Z., Pepin F., Durinck S., Korkola J.E., Griffith M., Hur J.S., Huh N., Chung J., Cope L., Fackler M.J., Umbricht C.B., Sukumar S., Seth P., Sukhatme V.P., Jakkula L.R., Lu Y.-L., Mills G.B., Cho R.J., Collisson E.A., van 't Veer L.J., Spellman P.T., Gray J.W.
Modeling precision treatment of breast cancer.
Genome Biol. 14:R110.1-R110.14(2013)

PubMed=24279929; DOI=10.1186/2049-3002-1-20
Dolfi S.C., Chan L.L.-Y., Qiu J., Tedeschi P.M., Bertino J.R., Hirshfield K.M., Oltvai Z.N., Vazquez A.
The metabolic demands of cancer cells are coupled to their size and protein synthesis rates.
Cancer Metab. 1:20.1-20.13(2013)

PubMed=24389870; DOI=10.1038/srep03576
Strauch M., Ludke A., Munch D., Laudes T., Galizia C.G., Martinelli E., Lavra L., Paolesse R., Ulivieri A., Catini A., Capuano R., Di Natale C.
More than apples and oranges -- detecting cancer with a fruit fly's antenna.
Sci. Rep. 4:3576-3576(2014)

PubMed=24456987; DOI=10.1186/1755-8166-7-8
Rondon-Lagos M., Verdun Di Cantogno L., Marchio C., Rangel N., Payan-Gomez C., Gugliotta P., Botta C., Bussolati G., Ramirez-Clavijo S.R., Pasini B., Sapino A.
Differences and homologies of chromosomal alterations within and between breast cancer cell lines: a clustering analysis.
Mol. Cytogenet. 7:8.1-8.14(2014)

PubMed=24618588; DOI=10.1371/journal.pone.0091433
Chernobrovkin A.L., Zubarev R.A.
Detection of viral proteins in human cells lines by xeno-proteomics: elimination of the last valid excuse for not testing every cellular proteome dataset for viral proteins.
PLoS ONE 9:E91433-E91433(2014)

PubMed=24670534; DOI=10.1371/journal.pone.0092047
Varma S., Pommier Y., Sunshine M., Weinstein J.N., Reinhold W.C.
High resolution copy number variation data in the NCI-60 cancer cell lines from whole genome microarrays accessible through CellMiner.
PLoS ONE 9:E92047-E92047(2014)

PubMed=25321415; DOI=10.1210/me.2014-1229
Li Y., Arao Y., Hall J.M., Burkett S.S., Liu L.-W., Gerrish K., Cavailles V., Korach K.S.
Research resource: STR DNA profile and gene expression comparisons of human BG-1 cells and a BG-1/MCF-7 clonal variant.
Mol. Endocrinol. 28:2072-2081(2014)

PubMed=25960936; DOI=10.4161/21624011.2014.954893
Boegel S., Lower M., Bukur T., Sahin U., Castle J.C.
A catalog of HLA type, HLA expression, and neo-epitope candidates in human cancer cell lines.
OncoImmunology 3:e954893.1-e954893.12(2014)

PubMed=25984343; DOI=10.1038/sdata.2014.35
Cowley G.S., Weir B.A., Vazquez F., Tamayo P., Scott J.A., Rusin S., East-Seletsky A., Ali L.D., Gerath W.F.J., Pantel S.E., Lizotte P.H., Jiang G.-Z., Hsiao J., Tsherniak A., Dwinell E., Aoyama S., Okamoto M., Harrington W., Gelfand E.T., Green T.M., Tomko M.J., Gopal S., Wong T.C., Li H.-B., Howell S., Stransky N., Liefeld T., Jang D., Bistline J., Meyers B.H., Armstrong S.A., Anderson K.C., Stegmaier K., Reich M., Pellman D., Boehm J.S., Mesirov J.P., Golub T.R., Root D.E., Hahn W.C.
Parallel genome-scale loss of function screens in 216 cancer cell lines for the identification of context-specific genetic dependencies.
Sci. Data 1:140035-140035(2014)

PubMed=25485619; DOI=10.1038/nbt.3080
Klijn C., Durinck S., Stawiski E.W., Haverty P.M., Jiang Z.-S., Liu H.-B., Degenhardt J., Mayba O., Gnad F., Liu J.-F., Pau G., Reeder J., Cao Y., Mukhyala K., Selvaraj S.K., Yu M.-M., Zynda G.J., Brauer M.J., Wu T.D., Gentleman R.C., Manning G., Yauch R.L., Bourgon R., Stokoe D., Modrusan Z., Neve R.M., de Sauvage F.J., Settleman J., Seshagiri S., Zhang Z.-M.
A comprehensive transcriptional portrait of human cancer cell lines.
Nat. Biotechnol. 33:306-312(2015)

PubMed=25807930; DOI=10.1002/anie.201500342
Broncel M., Serwa R.A., Ciepla P., Krause E., Dallman M.J., Magee A.I., Tate E.W.
Multifunctional reagents for quantitative proteome-wide analysis of protein modification in human cells and dynamic profiling of protein lipidation during vertebrate development.
Angew. Chem. Int. Ed. 54:5948-5951(2015)

PubMed=25828948; DOI=10.1093/jnci/djv073
Lee A.V., Oesterreich S., Davidson N.E.
MCF-7 cells -- changing the course of breast cancer research and care for 45 years.
J. Natl. Cancer Inst. 107:djv073.1-djv073.4(2015)

PubMed=25877200; DOI=10.1038/nature14397
Yu M., Selvaraj S.K., Liang-Chu M.M.Y., Aghajani S., Busse M., Yuan J., Lee G., Peale F.V., Klijn C., Bourgon R., Kaminker J.S., Neve R.M.
A resource for cell line authentication, annotation and quality control.
Nature 520:307-311(2015)

PubMed=25892236; DOI=10.1016/j.celrep.2015.03.050
Lawrence R.T., Perez E.M., Hernandez D., Miller C.P., Haas K.M., Irie H.Y., Lee S.-I., Blau C.A., Villen J.
The proteomic landscape of triple-negative breast cancer.
Cell Rep. 11:630-644(2015)

PubMed=26026074
Comsa S., Cimpean A.M., Raica M.
The story of MCF-7 breast cancer cell line: 40 years of experience in research.
Anticancer Res. 35:3147-3154(2015)

PubMed=26055192; DOI=10.1021/acs.jproteome.5b00375
Cifani P., Kirik U., Waldemarson S., James P.
Molecular portrait of breast-cancer-derived cell lines reveals poor similarity with tumors.
J. Proteome Res. 14:2819-2827(2015)

PubMed=26116361; DOI=10.1158/1535-7163.MCT-15-0143
Ribas R., Pancholi S., Guest S.K., Marangoni E., Gao Q., Thuleau A., Simigdala N., Polanska U.M., Campbell H., Rani A., Liccardi G., Johnston S.R.D., Davies B.R., Dowsett M., Martin L.-A.
AKT antagonist AZD5363 influences estrogen receptor function in endocrine-resistant breast cancer and synergizes with fulvestrant (ICI182780) in vivo.
Mol. Cancer Ther. 14:2035-2048(2015)

PubMed=26330541; DOI=10.1074/mcp.M115.050484
Wu X.-Y., Zahari M.S., Renuse S., Nirujogi R.S., Kim M.-S., Manda S.S., Stearns V., Gabrielson E.W., Sukumar S., Pandey A.
Phosphoproteomic analysis identifies focal adhesion kinase 2 (FAK2) as a potential therapeutic target for tamoxifen resistance in breast cancer.
Mol. Cell. Proteomics 14:2887-2900(2015)

PubMed=26589293; DOI=10.1186/s13073-015-0240-5
Scholtalbers J., Boegel S., Bukur T., Byl M., Goerges S., Sorn P., Loewer M., Sahin U., Castle J.C.
TCLP: an online cancer cell line catalogue integrating HLA type, predicted neo-epitopes, virus and gene expression.
Genome Med. 7:118.1-118.7(2015)

PubMed=27331101; DOI=10.1016/j.dib.2016.05.040
Aumsuwan P., Khan S.I., Khan I.A., Walker L.A., Dasmahapatra A.K.
Gene expression profiling and pathway analysis data in MCF-7 and MDA-MB-231 human breast cancer cell lines treated with dioscin.
Data Brief 8:272-279(2016)

PubMed=27362937; DOI=10.1371/journal.pone.0157290
Carrier M., Joint M., Lutzing R., Page A., Rochette-Egly C.
Phosphoproteome and transcriptome of RA-responsive and RA-resistant breast cancer cell lines.
PLoS ONE 11:E0157290-E0157290(2016)

PubMed=27377824; DOI=10.1038/sdata.2016.52
Mestdagh P., Lefever S., Volders P.-J., Derveaux S., Hellemans J., Vandesompele J.
Long non-coding RNA expression profiling in the NCI60 cancer cell line panel using high-throughput RT-qPCR.
Sci. Data 3:160052-160052(2016)

PubMed=27378269; DOI=10.1186/s12885-016-2452-5
Kangaspeska S., Hultsch S., Jaiswal A., Edgren H., Mpindi J.P., Eldfors S., Bruck O., Aittokallio T., Kallioniemi O.-P.
Systematic drug screening reveals specific vulnerabilities and co-resistance patterns in endocrine-resistant breast cancer.
BMC Cancer 16:378.1-378.17(2016)

PubMed=27397505; DOI=10.1016/j.cell.2016.06.017
Iorio F., Knijnenburg T.A., Vis D.J., Bignell G.R., Menden M.P., Schubert M., Aben N., Goncalves E., Barthorpe S., Lightfoot H., Cokelaer T., Greninger P., van Dyk E., Chang H., de Silva H., Heyn H., Deng X.-M., Egan R.K., Liu Q.-S., Mironenko T., Mitropoulos X., Richardson L., Wang J.-H., Zhang T.-H., Moran S., Sayols S., Soleimani M., Tamborero D., Lopez-Bigas N., Ross-Macdonald P., Esteller M., Gray N.S., Haber D.A., Stratton M.R., Benes C.H., Wessels L.F.A., Saez-Rodriguez J., McDermott U., Garnett M.J.
A landscape of pharmacogenomic interactions in cancer.
Cell 166:740-754(2016)

PubMed=27456714; DOI=10.1038/srep28994
Kleensang A., Vantangoli M.M., Odwin-DaCosta S., Andersen M.E., Boekelheide K., Bouhifd M., Fornace A.J. Jr., Li H.-H., Livi C.B., Madnick S., Maertens A., Rosenberg M., Yager J.D., Zhaog L., Hartung T.
Genetic variability in a frozen batch of MCF-7 cells invisible in routine authentication affecting cell function.
Sci. Rep. 6:28994-28994(2016)

PubMed=27761513; DOI=10.1016/j.dib.2016.09.025
Sarvaiya H.A., Lazar I.M.
Insulin stimulated MCF7 breast cancer cells: proteome dataset.
Data Brief 9:579-584(2016)

PubMed=27807467; DOI=10.1186/s13100-016-0078-4
Zampella J.G., Rodic N., Yang W.R., Huang C.R.L., Welch J., Gnanakkan V.P., Cornish T.C., Boeke J.D., Burns K.H.
A map of mobile DNA insertions in the NCI-60 human cancer cell panel.
Mob. DNA 7:20.1-20.11(2016)

PubMed=28196595; DOI=10.1016/j.ccell.2017.01.005
Li J., Zhao W., Akbani R., Liu W.-B., Ju Z.-L., Ling S.-Y., Vellano C.P., Roebuck P., Yu Q.-H., Eterovic A.K., Byers L.A., Davies M.A., Deng W.-L., Gopal Y.N.V., Chen G., von Euw E.M., Slamon D.J., Conklin D., Heymach J.V., Gazdar A.F., Minna J.D., Myers J.N., Lu Y.-L., Mills G.B., Liang H.
Characterization of human cancer cell lines by reverse-phase protein arrays.
Cancer Cell 31:225-239(2017)

PubMed=28287265; DOI=10.1021/acs.jproteome.6b00470
Yen T.-Y., Bowen S., Yen R., Piryatinska A., Macher B.A., Timpe L.C.
Glycoproteins in claudin-low breast cancer cell lines have a unique expression profile.
J. Proteome Res. 16:1391-1400(2017)

PubMed=28601559; DOI=10.1016/j.cels.2017.05.009
Bekker-Jensen D.B., Kelstrup C.D., Batth T.S., Larsen S.C., Haldrup C., Bramsen J.B., Sorensen K.D., Hoyer S., Orntoft T.F., Andersen C.L., Nielsen M.L., Olsen J.V.
An optimized shotgun strategy for the rapid generation of comprehensive human proteomes.
Cell Syst. 4:587-599.e4(2017)

PubMed=28889351; DOI=10.1007/s10549-017-4496-x
Saunus J.M., Smart C.E., Kutasovic J.R., Johnston R.L., Kalita-de Croft P., Miranda M., Rozali E.N., Vargas A.C., Reid L.E., Lorsy E., Cocciardi S., Seidens T., McCart Reed A.E., Dalley A.J., Wockner L.F., Johnson J., Sarkar D., Askarian-Amiri M.E., Simpson P.T., Khanna K.K., Chenevix-Trench G., Al-Ejeh F., Lakhani S.R.
Multidimensional phenotyping of breast cancer cell lines to guide preclinical research.
Breast Cancer Res. Treat. 167:289-301(2018)

PubMed=29273624; DOI=10.1101/gr.226019.117
Franco H.L., Nagari A., Malladi V.S., Li W.-Q., Xi Y.-X., Richardson D., Allton K.L., Tanaka K., Li J., Murakami S., Keyomarsi K., Bedford M.T., Shi X.-B., Li W., Barton M.C., Dent S.Y.R., Kraus W.L.
Enhancer transcription reveals subtype-specific gene expression programs controlling breast cancer pathogenesis.
Genome Res. 28:159-170(2018)

PubMed=30894373; DOI=10.1158/0008-5472.CAN-18-2747
Dutil J., Chen Z.-H., Monteiro A.N.A., Teer J.K., Eschrich S.A.
An interactive resource to probe genetic diversity and estimated ancestry in cancer cell lines.
Cancer Res. 79:1263-1273(2019)

PubMed=30971826; DOI=10.1038/s41586-019-1103-9
Behan F.M., Iorio F., Picco G., Goncalves E., Beaver C.M., Migliardi G., Santos R., Rao Y., Sassi F., Pinnelli M., Ansari R., Harper S., Jackson D.A., McRae R., Pooley R., Wilkinson P., van der Meer D.J., Dow D., Buser-Doepner C.A., Bertotti A., Trusolino L., Stronach E.A., Saez-Rodriguez J., Yusa K., Garnett M.J.
Prioritization of cancer therapeutic targets using CRISPR-Cas9 screens.
Nature 568:511-516(2019)

PubMed=31068700; DOI=10.1038/s41586-019-1186-3
Ghandi M., Huang F.W., Jane-Valbuena J., Kryukov G.V., Lo C.C., McDonald E.R. III, Barretina J.G., Gelfand E.T., Bielski C.M., Li H.-X., Hu K., Andreev-Drakhlin A.Y., Kim J., Hess J.M., Haas B.J., Aguet F., Weir B.A., Rothberg M.V., Paolella B.R., Lawrence M.S., Akbani R., Lu Y.-L., Tiv H.L., Gokhale P.C., de Weck A., Mansour A.A., Oh C., Shih J., Hadi K., Rosen Y., Bistline J., Venkatesan K., Reddy A., Sonkin D., Liu M., Lehar J., Korn J.M., Porter D.A., Jones M.D., Golji J., Caponigro G., Taylor J.E., Dunning C.M., Creech A.L., Warren A.C., McFarland J.M., Zamanighomi M., Kauffmann A., Stransky N., Imielinski M., Maruvka Y.E., Cherniack A.D., Tsherniak A., Vazquez F., Jaffe J.D., Lane A.A., Weinstock D.M., Johannessen C.M., Morrissey M.P., Stegmeier F., Schlegel R., Hahn W.C., Getz G., Mills G.B., Boehm J.S., Golub T.R., Garraway L.A., Sellers W.R.
Next-generation characterization of the Cancer Cell Line Encyclopedia.
Nature 569:503-508(2019)

PubMed=31698574; DOI=10.3934/mbe.2019325
Wei H.-C.
Mathematical modeling of tumor growth: the MCF-7 breast cancer cell line.
Math. Biosci. Eng. 16:6512-6535(2019)

PubMed=31978347; DOI=10.1016/j.cell.2019.12.023
Nusinow D.P., Szpyt J., Ghandi M., Rose C.M., McDonald E.R. III, Kalocsay M., Jane-Valbuena J., Gelfand E.T., Schweppe D.K., Jedrychowski M.P., Golji J., Porter D.A., Rejtar T., Wang Y.K., Kryukov G.V., Stegmeier F., Erickson B.K., Garraway L.A., Sellers W.R., Gygi S.P.
Quantitative proteomics of the Cancer Cell Line Encyclopedia.
Cell 180:387-402.e16(2020)

PubMed=34238275; DOI=10.1186/s12885-021-08511-2
Samson J., Derlipanska M., Zaheed O., Dean K.
Molecular and cellular characterization of two patient-derived ductal carcinoma in situ (DCIS) cell lines, ETCC-006 and ETCC-010.
BMC Cancer 21:790.1-790.20(2021)

PubMed=34320349; DOI=10.1016/j.celrep.2021.109441
Jochems F., Thijssen B., De Conti G., Jansen R., Pogacar Z., Groot K., Wang L.-Q., Schepers A., Wang C., Jin H.-J., Beijersbergen R.L., Leite de Oliveira R., Wessels L.F.A., Bernards R.
The cancer SENESCopedia: a delineation of cancer cell senescence.
Cell Rep. 36:109441.1-109441.22(2021)

PubMed=35042871; DOI=10.1038/s41523-021-00379-6
Rypens C., Bertucci F., Finetti P., Robertson F.M., Fernandez S.V., Ueno N.T., Woodward W.A., Van Golen K., Vermeulen P., Dirix L., Viens P., Birnbaum D., Devi G.R., Cristofanilli M., Van Laere S.
Comparative transcriptional analyses of preclinical models and patient samples reveal MYC and RELA driven expression patterns that define the molecular landscape of IBC.
NPJ Breast Cancer 8:12.1-12.12(2022)

PubMed=35839778; DOI=10.1016/j.ccell.2022.06.010
Goncalves E., Poulos R.C., Cai Z.-X., Barthorpe S., Manda S.S., Lucas N., Beck A., Bucio-Noble D., Dausmann M., Hall C., Hecker M., Koh J., Lightfoot H., Mahboob S., Mali I., Morris J., Richardson L., Seneviratne A.J., Shepherd R., Sykes E., Thomas F., Valentini S., Williams S.G., Wu Y.-X., Xavier D., MacKenzie K.L., Hains P.G., Tully B., Robinson P.J., Zhong Q., Garnett M.J., Reddel R.R.
Pan-cancer proteomic map of 949 human cell lines.
Cancer Cell 40:835-849.e8(2022)

Cross-references
Cell line collections (Providers) Abcam; ab257303
Abcam; ab271144
Abcam; ab277916
Abcam; ab288560
AddexBio; C0006008/402
ATCC; HTB-22
BCRC; 60436
BCRJ; 0162
CCTCC; GDC0055
CLS; 300273
DSMZ; ACC-115
ECACC; 86012803
IBRC; C10082
IBRC; C10682
ICLC; HTL95021
IZSLER; BS TCL 38
JCRB; JCRB0134
JCRB; NIHS0200 - Discontinued
KCB; KCB 200529YJ
KCB; KCB 200831YJ
KCLB; 30022
NCBI_Iran; C135
NCI-DTP; MCF7
RCB; RCB1904
TKG; TKG 0479
Ubigene; YC-D006
Cell line databases/resources CLO; CLO_0007601
CLO; CLO_0007605
CLO; CLO_0007606
CLO; CLO_0050868
MCCL; MCC:0000307
CLDB; cl3366
CLDB; cl3367
CLDB; cl3368
CLDB; cl3369
CLDB; cl3370
CLDB; cl3371
CLDB; cl3372
CLDB; cl3373
CLDB; cl3375
cancercelllines; CVCL_0031
CCRID; 1101HUM-PUMC000013
CCRID; 1101HUM-PUMC000328
CCRID; 3101HUMSCSP531
CCRID; 3101HUMTCHu74
CCRID; 4201HUM-CCTCC00055
Cell_Model_Passport; SIDM00148
Cosmic-CLP; 905946
DepMap; ACH-000019
DSMZCellDive; ACC-115
IGRhCellID; MCF7
IPD-IMGT/HLA; 12401
LINCS_HMS; 50029
LINCS_LDP; LCL-1460
Lonza; 113
SKY/M-FISH/CGH; 2814
SLKBase; 3572
TOKU-E; 2383
TOKU-E; 3748
Anatomy/cell type resources BTO; BTO:0000093
Biological sample resources BioSample; SAMN01821575
BioSample; SAMN01821646
BioSample; SAMN01821698
BioSample; SAMN03473276
BioSample; SAMN05292458
BioSample; SAMN10988179
ENCODE; ENCBS000AAA
ENCODE; ENCBS000RXG
ENCODE; ENCBS001AAA
ENCODE; ENCBS017ENC
ENCODE; ENCBS028FSB
ENCODE; ENCBS034XKZ
ENCODE; ENCBS035QUK
ENCODE; ENCBS035TSV
ENCODE; ENCBS036ENC
ENCODE; ENCBS037ENC
ENCODE; ENCBS050QMU
ENCODE; ENCBS053YJT
ENCODE; ENCBS056AAA
ENCODE; ENCBS094ENC
ENCODE; ENCBS095ENC
ENCODE; ENCBS096ENC
ENCODE; ENCBS097ENC
ENCODE; ENCBS098ENC
ENCODE; ENCBS102ENC
ENCODE; ENCBS103ENC
ENCODE; ENCBS104ENC
ENCODE; ENCBS105ENC
ENCODE; ENCBS108ENC
ENCODE; ENCBS110CZN
ENCODE; ENCBS123ZGI
ENCODE; ENCBS134PJO
ENCODE; ENCBS135SOE
ENCODE; ENCBS143XXF
ENCODE; ENCBS148TCA
ENCODE; ENCBS155VQC
ENCODE; ENCBS158RRU
ENCODE; ENCBS168ISE
ENCODE; ENCBS174OTK
ENCODE; ENCBS183ZAS
ENCODE; ENCBS195LAY
ENCODE; ENCBS200IWR
ENCODE; ENCBS216AOQ
ENCODE; ENCBS236AAA
ENCODE; ENCBS237AAA
ENCODE; ENCBS240AAA
ENCODE; ENCBS241AAA
ENCODE; ENCBS242AAA
ENCODE; ENCBS243AAA
ENCODE; ENCBS244AAA
ENCODE; ENCBS245AAA
ENCODE; ENCBS246AAA
ENCODE; ENCBS247AAA
ENCODE; ENCBS248AAA
ENCODE; ENCBS249AAA
ENCODE; ENCBS250AAA
ENCODE; ENCBS251AAA
ENCODE; ENCBS252AAA
ENCODE; ENCBS253AAE
ENCODE; ENCBS254AYH
ENCODE; ENCBS267CRP
ENCODE; ENCBS295JCF
ENCODE; ENCBS295PFW
ENCODE; ENCBS308QKF
ENCODE; ENCBS312USZ
ENCODE; ENCBS325VCY
ENCODE; ENCBS328UKJ
ENCODE; ENCBS331EJR
ENCODE; ENCBS345ZJP
ENCODE; ENCBS351GKC
ENCODE; ENCBS402YIK
ENCODE; ENCBS409BSE
ENCODE; ENCBS448KAT
ENCODE; ENCBS488MMM
ENCODE; ENCBS496HCC
ENCODE; ENCBS523HSQ
ENCODE; ENCBS530DHL
ENCODE; ENCBS536NWC
ENCODE; ENCBS540TUZ
ENCODE; ENCBS546VBU
ENCODE; ENCBS547AXB
ENCODE; ENCBS564FRY
ENCODE; ENCBS567IJO
ENCODE; ENCBS573TKZ
ENCODE; ENCBS581MUA
ENCODE; ENCBS584TFV
ENCODE; ENCBS609QTY
ENCODE; ENCBS614ENC
ENCODE; ENCBS615ENC
ENCODE; ENCBS616ENC
ENCODE; ENCBS616MBU
ENCODE; ENCBS637YEV
ENCODE; ENCBS661RDG
ENCODE; ENCBS670IYV
ENCODE; ENCBS697UNO
ENCODE; ENCBS705BBA
ENCODE; ENCBS726ASX
ENCODE; ENCBS737JTX
ENCODE; ENCBS746EOD
ENCODE; ENCBS747ZRJ
ENCODE; ENCBS748WRO
ENCODE; ENCBS758TZQ
ENCODE; ENCBS764AUT
ENCODE; ENCBS764NNP
ENCODE; ENCBS773JGQ
ENCODE; ENCBS778AGF
ENCODE; ENCBS789UPK
ENCODE; ENCBS842TPF
ENCODE; ENCBS866ZXX
ENCODE; ENCBS867ORK
ENCODE; ENCBS868OVR
ENCODE; ENCBS873NNF
ENCODE; ENCBS902LKX
ENCODE; ENCBS912WOF
ENCODE; ENCBS947NBH
ENCODE; ENCBS957OEW
ENCODE; ENCBS959SHH
ENCODE; ENCBS963BLD
ENCODE; ENCBS967MVZ
ENCODE; ENCBS968SNH
ENCODE; ENCBS973EAA
ENCODE; ENCBS974BZV
CRISP screens repositories BioGRID_ORCS_Cell_line; 940
Chemistry resources ChEMBL-Cells; CHEMBL3308403
ChEMBL-Targets; CHEMBL387
GDSC; 905946
PharmacoDB; MCF7_895_2019
PubChem_Cell_line; CVCL_0031
Encyclopedic resources Wikidata; Q1881253
Experimental variables resources EFO; EFO_0001203
Gene expression databases ArrayExpress; E-MTAB-38
ArrayExpress; E-MTAB-783
ArrayExpress; E-MTAB-2706
ArrayExpress; E-MTAB-2770
ArrayExpress; E-MTAB-3610
ArrayExpress; E-MTAB-11134
ArrayExpress; E-TABM-157
ArrayExpress; E-TABM-244
GEO; GSM1723
GEO; GSM2111
GEO; GSM2137
GEO; GSM2153
GEO; GSM50183
GEO; GSM50247
GEO; GSM69199
GEO; GSM73693
GEO; GSM115111
GEO; GSM155207
GEO; GSM156025
GEO; GSM185091
GEO; GSM185092
GEO; GSM211175
GEO; GSM274640
GEO; GSM276773
GEO; GSM276774
GEO; GSM276775
GEO; GSM276776
GEO; GSM276777
GEO; GSM276778
GEO; GSM276779
GEO; GSM320172
GEO; GSM344347
GEO; GSM344397
GEO; GSM350552
GEO; GSM378140
GEO; GSM388212
GEO; GSM383798
GEO; GSM383799
GEO; GSM383800
GEO; GSM421869
GEO; GSM459726
GEO; GSM472936
GEO; GSM481303
GEO; GSM510510
GEO; GSM533396
GEO; GSM533413
GEO; GSM590108
GEO; GSM679692
GEO; GSM679693
GEO; GSM679694
GEO; GSM736581
GEO; GSM736588
GEO; GSM739996
GEO; GSM739997
GEO; GSM739998
GEO; GSM749760
GEO; GSM750771
GEO; GSM750777
GEO; GSM750778
GEO; GSM750801
GEO; GSM783949
GEO; GSM799320
GEO; GSM799383
GEO; GSM816438
GEO; GSM816627
GEO; GSM816670
GEO; GSM822295
GEO; GSM822305
GEO; GSM825711
GEO; GSM827593
GEO; GSM839033
GEO; GSM847394
GEO; GSM847490
GEO; GSM844586
GEO; GSM844587
GEO; GSM887291
GEO; GSM888366
GEO; GSM923442
GEO; GSM935445
GEO; GSM935477
GEO; GSM935563
GEO; GSM945269
GEO; GSM945274
GEO; GSM945854
GEO; GSM945857
GEO; GSM967819
GEO; GSM967823
GEO; GSM970217
GEO; GSM970218
GEO; GSM987741
GEO; GSM987742
GEO; GSM987743
GEO; GSM1008565
GEO; GSM1008581
GEO; GSM1008603
GEO; GSM1008904
GEO; GSM1010734
GEO; GSM1010764
GEO; GSM1010768
GEO; GSM1010769
GEO; GSM1010783
GEO; GSM1010791
GEO; GSM1010800
GEO; GSM1010811
GEO; GSM1010825
GEO; GSM1010837
GEO; GSM1010838
GEO; GSM1010839
GEO; GSM1010844
GEO; GSM1010860
GEO; GSM1010861
GEO; GSM1010862
GEO; GSM1010863
GEO; GSM1010864
GEO; GSM1010889
GEO; GSM1010891
GEO; GSM1010892
GEO; GSM1022658
GEO; GSM1022663
GEO; GSM1029440
GEO; GSM1029441
GEO; GSM1029442
GEO; GSM1029443
GEO; GSM1029444
GEO; GSM1029445
GEO; GSM1029446
GEO; GSM1029447
GEO; GSM1029448
GEO; GSM1029449
GEO; GSM1040306
GEO; GSM1040376
GEO; GSM1053687
GEO; GSM1068138
GEO; GSM1068139
GEO; GSM1153389
GEO; GSM1172885
GEO; GSM1178359
GEO; GSM1178360
GEO; GSM1181258
GEO; GSM1181263
GEO; GSM1214589
GEO; GSM1238132
GEO; GSM1322270
GEO; GSM1322272
GEO; GSM1322273
GEO; GSM1322274
GEO; GSM1328112
GEO; GSM1374643
GEO; GSM1374644
GEO; GSM1374645
GEO; GSM1401653
GEO; GSM1670076
GEO; GSM1833626
GEO; GSM2046560
GEO; GSM2046561
GEO; GSM2046562
GEO; GSM2046563
GEO; GSM2046564
GEO; GSM2046565
GEO; GSM2046566
GEO; GSM2046567
GEO; GSM2046568
GEO; GSM2046569
GEO; GSM2046570
GEO; GSM2046571
GEO; GSM2046572
GEO; GSM2046573
GEO; GSM2046574
GEO; GSM2046575
GEO; GSM2046576
GEO; GSM2046577
GEO; GSM2046578
GEO; GSM2046579
GEO; GSM2046580
GEO; GSM2046581
GEO; GSM2046582
GEO; GSM2046583
GEO; GSM2046584
GEO; GSM2046585
GEO; GSM2046586
GEO; GSM2046587
GEO; GSM2046588
GEO; GSM2046589
GEO; GSM2046590
GEO; GSM2046591
GEO; GSM2046592
GEO; GSM2046593
GEO; GSM2046594
GEO; GSM2046595
GEO; GSM2046596
GEO; GSM2046597
GEO; GSM2046598
GEO; GSM2046599
GEO; GSM2046600
GEO; GSM2046601
GEO; GSM2046602
GEO; GSM2046603
GEO; GSM2046604
GEO; GSM2046605
GEO; GSM2046606
GEO; GSM2046607
GEO; GSM2095708
GEO; GSM2095709
GEO; GSM2124642
GEO; GSM2136630
GEO; GSM2136631
GEO; GSM2136632
GEO; GSM2136633
GEO; GSM2136634
GEO; GSM2136635
GEO; GSM2176269
GEO; GSM2176270
GEO; GSM2258722
GEO; GSM2258723
GEO; GSM2258724
GEO; GSM2258725
GEO; GSM2258726
GEO; GSM2258727
GEO; GSM2258728
GEO; GSM2258729
GEO; GSM2258730
GEO; GSM2258731
GEO; GSM2258732
GEO; GSM2258733
GEO; GSM2258734
GEO; GSM2258735
GEO; GSM2258736
GEO; GSM2258737
GEO; GSM2258738
GEO; GSM2258739
GEO; GSM2258947
GEO; GSM2258948
GEO; GSM2258949
Medical resources MeSH; D061986
Metabolomic databases MetaboLights; MTBLS177
MetaboLights; MTBLS182
MetaboLights; MTBLS183
MetaboLights; MTBLS241
MetaboLights; MTBLS337
MetaboLights; MTBLS430
Polymorphism and mutation databases Cosmic; 687490
Cosmic; 755293
Cosmic; 809239
Cosmic; 871143
Cosmic; 875876
Cosmic; 877449
Cosmic; 894096
Cosmic; 897419
Cosmic; 904373
Cosmic; 905946
Cosmic; 912001
Cosmic; 921976
Cosmic; 923059
Cosmic; 934534
Cosmic; 944293
Cosmic; 947352
Cosmic; 949189
Cosmic; 970089
Cosmic; 979723
Cosmic; 991328
Cosmic; 997916
Cosmic; 1000123
Cosmic; 1010932
Cosmic; 1017161
Cosmic; 1018463
Cosmic; 1019310
Cosmic; 1046936
Cosmic; 1047712
Cosmic; 1066224
Cosmic; 1071901
Cosmic; 1092612
Cosmic; 1102382
Cosmic; 1136341
Cosmic; 1152527
Cosmic; 1175832
Cosmic; 1176603
Cosmic; 1176648
Cosmic; 1183770
Cosmic; 1287893
Cosmic; 1289391
Cosmic; 1305382
Cosmic; 1308991
Cosmic; 1312369
Cosmic; 1326278
Cosmic; 1434950
Cosmic; 1436031
Cosmic; 1477426
Cosmic; 1481420
Cosmic; 1523770
Cosmic; 1524349
Cosmic; 1571788
Cosmic; 1603215
Cosmic; 1609459
Cosmic; 1945860
Cosmic; 1995500
Cosmic; 1998454
Cosmic; 2162161
Cosmic; 2165024
Cosmic; 2301233
Cosmic; 2301526
Cosmic; 2307194
Cosmic; 2318370
Cosmic; 2361358
Cosmic; 2525755
Cosmic; 2553502
Cosmic; 2560248
Cosmic; 2668278
Cosmic; 2750523
IARC_TP53; 21079
LiGeA; CCLE_648
Progenetix; CVCL_0031
Proteomic databases PRIDE; PXD000275
PRIDE; PXD000281
PRIDE; PXD000309
PRIDE; PXD000442
PRIDE; PXD000623
PRIDE; PXD000691
PRIDE; PXD000815
PRIDE; PXD001274
PRIDE; PXD001352
PRIDE; PXD001812
PRIDE; PXD001863
PRIDE; PXD002104
PRIDE; PXD002192
PRIDE; PXD002395
PRIDE; PXD002421
PRIDE; PXD002998
PRIDE; PXD003704
PRIDE; PXD004051
PRIDE; PXD004085
PRIDE; PXD004357
PRIDE; PXD004452
PRIDE; PXD005032
PRIDE; PXD005390
PRIDE; PXD005940
PRIDE; PXD005942
PRIDE; PXD005946
PRIDE; PXD006732
PRIDE; PXD008222
PRIDE; PXD023223
PRIDE; PXD024293
PRIDE; PXD030304
Sequence databases EGA; EGAS00001000610
EGA; EGAS00001000978
EGA; EGAS00001002554
Entry history
Entry creation04-Apr-2012
Last entry update30-Jan-2024
Version number48